EP2699165B1 - System for optically evaluating proximity to the inferior alveolar nerve in situ - Google Patents
System for optically evaluating proximity to the inferior alveolar nerve in situ Download PDFInfo
- Publication number
- EP2699165B1 EP2699165B1 EP12774529.7A EP12774529A EP2699165B1 EP 2699165 B1 EP2699165 B1 EP 2699165B1 EP 12774529 A EP12774529 A EP 12774529A EP 2699165 B1 EP2699165 B1 EP 2699165B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- optical fiber
- probe system
- spectral absorption
- light
- excitation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002698 mandibular nerve Anatomy 0.000 title description 70
- 238000011065 in-situ storage Methods 0.000 title description 5
- 239000000523 sample Substances 0.000 claims description 72
- 238000010521 absorption reaction Methods 0.000 claims description 56
- 239000013307 optical fiber Substances 0.000 claims description 46
- 230000003595 spectral effect Effects 0.000 claims description 45
- 230000005284 excitation Effects 0.000 claims description 31
- 210000001367 artery Anatomy 0.000 claims description 27
- 239000008280 blood Substances 0.000 claims description 27
- 210000004369 blood Anatomy 0.000 claims description 27
- 239000000835 fiber Substances 0.000 claims description 27
- 238000003384 imaging method Methods 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 13
- 238000005305 interferometry Methods 0.000 claims description 12
- 230000017531 blood circulation Effects 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 6
- 230000031700 light absorption Effects 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 230000036962 time dependent Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 description 52
- 210000001519 tissue Anatomy 0.000 description 44
- 238000012014 optical coherence tomography Methods 0.000 description 36
- 210000000988 bone and bone Anatomy 0.000 description 34
- 230000003287 optical effect Effects 0.000 description 28
- 210000004373 mandible Anatomy 0.000 description 24
- 238000013459 approach Methods 0.000 description 21
- 238000005553 drilling Methods 0.000 description 21
- 239000007943 implant Substances 0.000 description 21
- 230000001054 cortical effect Effects 0.000 description 16
- 238000001514 detection method Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 238000002591 computed tomography Methods 0.000 description 10
- 238000010586 diagram Methods 0.000 description 8
- 210000004977 neurovascular bundle Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 210000005036 nerve Anatomy 0.000 description 7
- 238000006213 oxygenation reaction Methods 0.000 description 7
- 230000035515 penetration Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 239000004053 dental implant Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 206010031264 Osteonecrosis Diseases 0.000 description 4
- 108010064719 Oxyhemoglobins Proteins 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000001847 jaw Anatomy 0.000 description 4
- 238000010883 osseointegration Methods 0.000 description 4
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000028389 Nerve injury Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 108010002255 deoxyhemoglobin Proteins 0.000 description 3
- 230000020169 heat generation Effects 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000002262 irrigation Effects 0.000 description 3
- 238000003973 irrigation Methods 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008764 nerve damage Effects 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- 238000004497 NIR spectroscopy Methods 0.000 description 2
- 206010040030 Sensory loss Diseases 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000009091 Cordyline terminalis Nutrition 0.000 description 1
- 244000289527 Cordyline terminalis Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000009543 diffuse optical tomography Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000007340 echolocation Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 1
- 229960004657 indocyanine green Drugs 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 210000003901 trigeminal nerve Anatomy 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/16—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans
- A61B17/17—Guides or aligning means for drills, mills, pins or wires
- A61B17/1703—Guides or aligning means for drills, mills, pins or wires using imaging means, e.g. by X-rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/16—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans
- A61B17/1662—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans for particular parts of the body
- A61B17/1673—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans for particular parts of the body for the jaw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4538—Evaluating a particular part of the muscoloskeletal system or a particular medical condition
- A61B5/4542—Evaluating the mouth, e.g. the jaw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/489—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/4893—Nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C1/00—Dental machines for boring or cutting ; General features of dental machines or apparatus, e.g. hand-piece design
- A61C1/08—Machine parts specially adapted for dentistry
- A61C1/082—Positioning or guiding, e.g. of drills
- A61C1/084—Positioning or guiding, e.g. of drills of implanting tools
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C1/00—Dental machines for boring or cutting ; General features of dental machines or apparatus, e.g. hand-piece design
- A61C1/08—Machine parts specially adapted for dentistry
- A61C1/088—Illuminating devices or attachments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C19/00—Dental auxiliary appliances
- A61C19/04—Measuring instruments specially adapted for dentistry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0089—Implanting tools or instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B2034/2046—Tracking techniques
- A61B2034/2055—Optical tracking systems
- A61B2034/2057—Details of tracking cameras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/306—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
Definitions
- the invention relates to methods and systems for evaluating proximity to a target, more specifically, for evaluating proximity to a nerve.
- Dental implants are a widely accepted treatment for the partially or completely edentulous patient. Dental implants are the fastest growing procedure in dentistry today. It is a 1 billion dollar industry in the USA. Dental implants offer a suitable alternative to mucosal adhering dentures and allow a more natural option for the patient. Implants have a high success rate when given proper care and when post-surgical instructions are followed. Dental implants can be in the form of a single tooth replacement, or can replace a series or an entire set of teeth. The basic implant procedure involves drilling a channel in the mandible where an artificial root is surgically inserted. A dental prosthesis is then placed onto the frame of the artificial root. Within a few months of recovery, the patient should have a fully integrated and functional prosthesis.
- Implant procedures are not without complications.
- the goal of an implant procedure is to attain a successful level of osseointegration.
- Osseointegration is defined as the direct anchorage of an implant by the formation of bony tissue around the implant without the growth of fibrous tissue at the bone-implant interface. Implants surrounded with fibrous tissue show mobility when a load is applied. The successfully osseointegrated implant shows no mobility when loaded.
- Other major factors for the successful implant depend mainly on the type of jaw treated, the density of the bone, and the length of the implant. Implant length is the depth created by the surgeon upon drilling a channel in the mandible. Short implants have a length of less than 10 mm and are noted to have larger failure rates. Hence the need to create sufficient length for successful osseointegration of implants within the mandible is a priority.
- IAN inferior alveolar nerve
- a surgical drill which is able to detect the proximity and/or location of the IAN in the mandible, preferably during implant procedures.
- the sensor device should allow the drill to approach closely, but not impair or damage the IAN within an acceptable error limit of the intraosseous canal.
- a system that automatically terminates drill action when in close range of the IAN would be most desirable.
- the inferior alveolar nerve 12 is a branch of the mandibular nerve, which stems from the trigeminal nerve system.
- the IAN 12 enters an intraosseous canal through the mandibular foramen in the posterior portion of the mandible.
- the nerve continues its path within the mandible 10 and then exits through the mental foramen.
- the IAN 12 is closely associated with the inferior alveolar artery and both structures are covered in a tough sheath of connective tissue.
- the diameter of the entire bundle varies between patients but averages at 2.53 ā 0.29 mm [ C.D. Morris et al., J. Oral Maxillo. Surg., 68:2833-2836, 2010 ].
- the intraosseous canal is a hollow channel and in most cases has borders with defined walls which may be consistent throughout the length of the canal.
- the diameter of this canal is known to be 2.0 to 2.6 mm.
- the canal walls may either be composed of cortical bone, or in lesser frequency, may be continuous and uniform with the surrounding trabecular bone.
- Many patients have canals which abruptly become uniform and continuous with surrounding cancellous bone within proximity of the mental foramen.
- the intraosseous canal is present in many patients, it is not a consistent feature within the mandibles of every individual. Dissection studies show that cortical walls and distinct osseous canals within mandibles are not always present. Some specimens of IAN were shown to travel the trabecular marrow spaces without any defined canal present.
- the position of the IAN 12 within the mandible 10 is highly variable. In one dissection study, the position of the IAN varied in position from the sub-dental portion below the molar roots (See FIG. 1 ), to an inferior position near the bottom ridge of the mandible 10 (See FIG. 2 ). A feature which was not frequent, but was observed, was the splitting of the IAN bundle into diffuse branches without a defined intraosseous canal.
- the general imaging methods currently used by surgeons to assess the position of the IAN are Panoramic X-ray, Computed Tomography (CT) scan, and Microradiograph (MR) imaging. As some patients may lack an osseous canal and an IAN bundle altogether, preoperative imaging is imperative. X-rays are usually taken in a panoramic fashion, encircling the entire mandible. This presents a global view of the mandible and images potential implant placement sites. The limitations of this technique are that it provides no information about mandible thickness and suffers from a distortion factor of about 25%. A more modern approach to the imaging of the mandible is the CT scan. This method is able to generate overlapping images through computer software programs.
- drilling is used to create channels within the mandible for the placement of artificial roots.
- the drilling operation performed on the mandible must traverse a cortical bone layer and into a cancellous bone mass.
- heat is generated at the apex of the drill bit. Some of this heat is absorbed by the surrounding bone, raising its temperature.
- An implication of temperature rise and heat generation from machining bone is thermal osteonecrosis. Irreversible thermal osteonecrosis occurs when bone temperature reaches and exceeds 47°C. With irreversible osteonecrosis, adequate osseointegration could be inhibited, thus reducing the chances for a successful implant.
- tissue temperatures can range from 31-56°C. An irrigation system is included in most surgical drills for this purpose.
- Water is injected through an orifice from the apex of the drill bit into the immediate drilling site. This acts to cool the drilling site, and functions to prevent thermal osteonecrosis.
- the most important parameters are drill speed, feed rate and drill diameter. Hence with irrigation, adjustment and control of these parameters can help to reduce heat generation when drilling in bone.
- drill sensor technology is not aimed at discerning the media situated at the drill-bone interface.
- Technology is more focused on detecting and imaging wear on drill burs and machinery.
- drill detection systems aimed at bone machining applications.
- a mechatronic system developed by Bouazza-Marouf and Ong [ Ong, F.R., Bouazza-Marouf, K.; 1999; The detection of drill bit break-through for the enhancement of safety in mechatronic assisted orthopaedic drilling; MECHATRONICS 9: 565-588 ] is able to discern drill break-through from inherent fluctuations in bone structure when drilling long bones. This system is able to detect differences in force through an electronic logic algorithm.
- the drawback here is that a certain, constant force is applied and the drill bit feed rate into the bone media is constant.
- drilling with constant force and feed rate would not be used due to variability in bony tissues within the body and between patients.
- the mechatronic system was also not able to discern latent non-osseous tissue.
- the application of this system for the purpose of long implant placement within the mandible would not be desirable as bone breakthrough is the arresting factor for this system.
- the proximity sensor operating range should be within this 2 mm boundary, although a longer distance of operation would be useful.
- the axial resolution of the sensor should be as high as possible.
- the first approach is based on Low Coherence Interferometry (LCI).
- a LCI probe can be built to operate in A-mode (i.e. point-scan only, no image).
- LCI presents similar results to ultrasound echolocation and provides a high-resolution measurement of the tissue layers structure based on back-scattered light intensity from those layers.
- the measurements being optical in nature, the axial resolution of this technique is at least ten times better than with ultrasound, at the cost of a much lower depth penetration (typ. resolutions in ā 10 ā m at maximal depths of ā 1.5 mm, depending on tissues optical absorption and scattering properties).
- the particular imaging extension of this technique i.e B-mode scanning, is known in the art as Optical Coherence Tomography (OCT).
- OCT Optical Coherence Tomography
- FIG. 3 shows an embodiment of a standard time-domain LCI or OCT system 30 using a low coherence light source 32 (typically a superluminescent LED or pulsed laser) and an interferometer configuration 34 for performing a longitudinal scanning 36 and a lateral scanning 38 .
- a low coherence light source 32 typically a superluminescent LED or pulsed laser
- an optical arrangement 40 is used for implementing the lateral scanning 38 while an optical arrangement 42 comprising a moving mirror 44 is used for implementing the longitudinal scanning 36 .
- a signal processor 46 may be used in conjunction with a computer 48 for signal processing purposes.
- Newer designs, as the systems 50 and 52 shown in FIGS. 4A and 4B respectively, involve detecting in the Fourier domain or using frequency-swept light sources to disband with the traditional time-pulsed requirement of the incident light emission.
- the system 50 comprises a low coherence source (LCS) 54 , an interferometer sub-assembly 56 provided with a beamsplitter (BS) 58 and a reference mirror (REF) 60 .
- the system 50 also comprises a diffraction grating (DG) 62 and a camera (CAM) 64 for detecting light back-scattered by the sample (SMP) 66 .
- a digital signal processor (DSP) 68 is operatively connected to the camera 64 for providing an OCT image based on the back-scattered light.
- the system 52 of FIG. 4B uses a swept source (SS) 72 in place of the low coherence source 54 of FIG. 4A and a photodetector (PD) 70 .
- SS swept source
- PD photodetector
- An A-Mode fibered LCI probe can be designed in a compact form small enough to fit within a dental drill bit, according to one embodiment. Tissue interfaces will appear as an increase in the back-scattered signal intensity.
- a B-mode 2D image can be generated by building the LCI / OCT probe with an integrated forward-looking proximal or distal scanner, as it should become apparent to the skilled addressee.
- an interface signal will be generated either by the canal wall or the nerve bundle itself and will be visible in real time to the dental surgeon as long as the interface is within the penetration depth range of the instrument.
- FIG. 5 illustrates a low coherence interferometry probe system 100 for evaluating proximity to a tissue layer 102 , according to the above detailed technique and according to one embodiment.
- the probe system 100 comprises a low coherence light source 104 for generating low coherence excitation light 106 , an excitation optical fiber 108 to bring the low coherence excitation light 106 near the tissue layer 102 and a collection optical fiber 110 for capturing back-scattered light from the tissue layer 102 .
- the probe system 100 also comprises a low coherence interferometry sub-system 112 operatively connected to the excitation optical fiber 108 and the collection optical fiber 110 and having a beam splitter 114 and a reference mirror 116 .
- a digital signal processor 118 operatively connected to the low coherence interferometry sub-system 112 is used for evaluating a distance 120 to the tissue layer 102 based on the back-scattered light received by the collection optical fiber 110 .
- FIG. 17 illustrates a low coherence interferometry probe method for evaluating proximity to a tissue layer, according to one embodiment.
- a low coherence excitation light is generated.
- the low coherence excitation light is brought near the tissue layer.
- back-scattered light from the tissue layer is captured.
- interferometry between the low coherence excitation light and the back-scattered light is performed for providing an interference signal.
- the interference signal is processed for evaluating a distance to the tissue layer.
- a first approximation model can provide an evaluation of the order of magnitude of the return signal.
- the probing device would operate from within the trabecular bone to identify the artery from the IAN neurovascular bundle.
- Trabecular bone is a complex structure composed of cortical bone and bone marrow arranged in "cells", similar to a beehive. Optically, this structure may be represented in a one dimensional model 200 where three layers 202 , 204 , 206 are stacked vertically, each representing cortical bone, bone marrow and arterial blood, as illustrated in FIG. 16 .
- the blood layer thickness varies over time in a periodic fashion to represent the blood volume change in the arteries due to the cardiac cycle. The thickness of the bone and marrow layers is dependent on the porosity of the trabecular structure.
- d HbO2 will change due to the volume variation occurring with pulsating blood flow.
- d HbO2-baseline is the average thickness of the layer
- 0 ā ā d ā 1 is the maximum fractional thickness change due to pulsating blood flow
- t is time
- f is the blood pulse frequency in Hz.
- the HbO2 attenuation coefficient should also be considered a time-dependent value as it is related to blood oxygenation levels in the patient, thus dependent on the proportions of oxy- and deoxy-hemoglobin in arterial blood.
- the variation of blood oxygenation will generally be on a much longer time scale than the variations due to the patient's pulse. Strong and sudden variations of blood oxygenation are rare and indicative of a serious health condition that is unlikely to be encountered in the normal operation of the IAN sensor. Nevertheless, monitoring of blood oxygenation with a pulse oxymeter is considered a good practice in the utilization of such a sensor, if only as a check point for the sensor's calibration, as detailed below.
- the attenuation coefficient was however assumed to be a constant.
- Equs. (2)-(4) the model was built to provide an order of magnitude for the optical signal intensity over time to be expected from such an approach.
- the near infrared spectroscopy (NIRS) based sensor goal is to measure the thickness d total of trabecular bone tissue between the probe (or drill) tip and the neurovascular bundle containing the IAN.
- a lock-in amplifier may be used to establish the magnitude of the oscillating signal and circumvent the DC signal that is influenced by the static trabecular tissue, as detailed below.
- FIG. 7 shows a spectral absorption probe system 300 for evaluating proximity to an artery 302 , according to the above detailed technique and according to one embodiment.
- the probe system 300 comprises a light source 304 for generating excitation light 306 having a wavelength adapted for absorption by blood chromophores, an excitation optical fiber 308 to bring the excitation light 306 near the artery 302 and a collection optical fiber 310 for capturing back-scattered light from the artery 302 .
- the probe system 300 comprises a light detector 312 operatively connected to the collection optical fiber 310 and a signal processor 314 operatively connected to the light detector 312 for determining a distance 320 to the artery 302 based on the back-scattered light and on Beer-Lambert law of light absorption using a value for surrounding tissue attenuation coefficient ( ā eff).
- FIG. 18 illustrates a spectral absorption probe method for evaluating proximity to an artery, according to one embodiment.
- an excitation light having a wavelength adapted for absorption by blood chromophores is generated.
- the excitation light is brought near the artery.
- back-scattered light is captured from the artery.
- the back-scattered light from the artery is processed for determining a distance to the artery based on Beer-Lambert law of light absorption using a value for surrounding tissue attenuation coefficient ( ā eff).
- the artery is part of the IAN bundle, locating it is almost equivalent to locating the nerve.
- This approach can be implemented in a similar package as the LCI / OCT fiber probe that can fit within the dental drill bit.
- the blood pulse can be used to eliminate all background signals via AC-coupling of the detector or lock-in amplification.
- the signal amplitude can then be used to assess the distance from the probe to the IAN bundle based on Beer-Lambert's law.
- a calibration process is however typically required before use in situ due to patient's tissues variability of optical properties.
- the approach relies on the absorption of oxyhemoglobin, which itself will potentially vary according to blood oxygen saturation.
- the approach might benefit from the probe being used in conjunction with a pulse oxymeter that would monitor oxygen saturation levels and thus, indirectly account for variations of the blood attenuation coefficient.
- a variation on this approach uses the same spectral principle as the pulse oxymeter, utilizing two wavelengths (typically, 660 nm to target deoxyhemoglobin and 850 nm to target oxyhemoglobin, but generally comprised between 650 nm and 900 nm), as shown in FIG. 6 which illustrates a drill-integrated IAN sensor 600 based on the NIR spectral absorption technique.
- distance can be obtained by isolating the distance variable (d) in Equ.
- the calibration for the spectral absorption technique may be integrated within the standard configuration if a lock-in amplifier (not shown) is used.
- a lock-in amplifier (not shown) is used.
- an intensity-modulated light excitation of modulation frequency f (typ. ā 100 MHz range) and modulation depth M1 propagating in the tissues will suffer phase retardation and reduction of the modulation depth as a function of the attenuation properties of the traversed medium.
- the retrieved signal has the same frequency as the incident one, but due to absorption and scattering in the medium, it suffers a phase shift ā and an attenuation of the modulation depth M2 relative to the incident signal.
- the change in phase ā and modulation depth ā M is correlated to the average attenuation coefficient and can be used to extract the parameter ā eff in Equ. 1.
- This method is known in the art of Diffuse Optical Tomography.
- the modulation frequency should be in the range of about 100 MHz to 500 MHz.
- limitations in current lock-in amplifier electronics make most affordable conventional devices to operate up to the hundreds of kHz range.
- the light source 402 is driven at high frequency with a light source driver 404 , for example at 200 MHz, to insure adequate resolution on the extracted values ā and ā M.
- a local oscillator 406 generates a slightly larger frequency, larger by 50 kHz as a non-limitative example.
- the oscillator 406 and the driver 404 are phase-locked by a PLL circuit 408 .
- the detection channel 412 operates similarly and a standard, low-bandwidth dual-phase lock-in amplifier 414 can then be used.
- the positioning of the probe for calibration can skew the calibration measurement.
- the method might thus need an additional step where the instrument is pre-calibrated with an appropriate optical phantom (not shown) with known attenuation properties supplied with the device, before the in-patient calibration step. This way, a relative value to the phantom properties would be obtained and should be enough for the proper operation of the sensor.
- the calibration of the device for the patient's jaw tissues may be made at the beginning or at an early phase of the drilling process by the surgeon, before enabling the sensor, which is of great advantage.
- FIG. 10A shows an embodiment wherein the sensor is built as a standalone fiber optic device 500 contained within a biocompatible metallic rod 502 .
- the rod 502 contains two optical fibers 504 , 506 (single- or multimode) along its axial direction. One fiber serves to bring the excitation light within the tissues while the other captures the back-scattered light. Fibers 504 , 506 run parallel to each other and are separated by an adequate distance (1-2 mm) to fit into the hole bored by the dental drill bit (typ. 2 mm dia.). The skilled addressee will appreciate that the separation between the two fibers 504 , 506 should be as large as possible to maximize penetration depth.
- the fiber probe itself is connected to the device back-end.
- the excitation fiber is connected to a light source (either LED, laser or other source) or multiple light sources each having an appropriate wavelength for optimized absorption by blood chromophores (mainly oxy- and deoxyhemoglobin). Typical wavelengths are around 660 nm and 850 nm.
- the light source output could be modulated at a reference frequency in the kHz range.
- the collection fiber is connected to an appropriate light detector such as a photodiode, an avalanche photodiode (APD), a photomultiplier tube (PMT), a camera or the like.
- the detector output signal is either AC-coupled or connected to a lock-in amplifier operating at the same reference frequency as the light source modulation.
- the goal of the modulation signal or the AC-coupling is to reject background signals coming from other tissues than the flowing arterial blood.
- a variation of this embodiment makes use of a varying input optical power into the tissue to establish the neurovascular bundle position relative to the probe based on an intensity threshold approach, where larger input powers will statistically increase linearly the number of photons reaching larger depths, thus improving the chance of detecting some of these photons that might probe the neurovascular bundle.
- FIG. 10B shows another embodiment similar to the one shown in FIG. 10A in shape but implementing the OCT approach.
- a single fiber 508 can be used for illumination and collection purposes. Due to the difference in requirements between OCT and the spectral absorption concept, the fiber probe should be made of one or multiple single-mode optical fibers to prevent detrimental dispersion and spatial propagation modes mixing, according to one embodiment.
- the back-end of the probe utilizes classical OCT configurations, such as time-domain-based, frequency-domain OCT or swept-source-based implementations, as previously detailed.
- the back-end is entirely fiberized and uses fiber couplers to connect with the probe itself, as is well-known in the art.
- the probe forward-looking configuration can be implemented for B-mode scanning, by integrating a proximal scanning system installed in the back-end coupled to a bundle of single mode optical fibers, or through a distal scanning mechanism integrated into the probe head itself that would use one single-mode optical fiber.
- any of the described embodiments can be integrated at the center of the drill bit 610 of a dental surgery drill.
- the center of a dental drill bit 610 can have a hollow core 602 to allow for cooling water to circulate down to the drilling site 604 .
- the fiber probe can be inserted within this hollow core 602 .
- Combined OCT / Spectral absorption probe Such a combined configuration uses the advantages of each approach.
- the spectral absorption approach has potentially a greater detection range, while the OCT approach is more straightforward and offer potentially better resolution at short range.
- a combined sensor probe could thus potentially identify roughly the position of the IAN bundle at a distance with the spectral absorption mode and then switch to an OCT approach when close to the IAN (typ. within 1.5 mm).
- the sensor construction would require two or three optical fibers grouped in a bundle.
- a single-mode fiber would bring the excitation light.
- a second single-mode fiber would be used for OCT light collection, while a third multimode fiber would be used for the spectral absorption mode light collection channel.
- the single-mode excitation fiber could double-up as the collection fiber for the OCT technique.
- FIG. 11 shows an embodiment of a disjointed spectral absorption IAN sensor 700 .
- one or multiple excitation optical fibers 702 are positioned on the side of the gum or jawbone 704 , outside of the probe handpiece 706 itself (or the drill bit), while the detection optical fiber 708 is still integrated in the probe handpiece 706 , within the drilling hole 710 in the bone 704 .
- Such a configuration allows larger separation of the source and collection channels, which will increase depth sensitivity of the technique. Indeed, as previously mentioned, in back-reflected diffuse optical sensing, the depth of penetration is increased with source-detector separation.
- the source and collection channels can be reversed, with the detection being done laterally on the gum and the illumination being integrated in the drill bit, or probe handpiece.
- using multiple optical fibers built in a linear array may provide refined measurements of the neurovascular bundle's position in the jaw.
- FIG. 12 illustrates a double-clad optical fiber-based IAN sensor handpiece 800 which may be used alternatively to the use of two optical fibers in the probe.
- the core 802 of the double-clad optical fiber 804 is used as the excitation channel to send light into tissues and the first cladding 806 acts as the collection channel.
- the core 802 is built for single mode propagation.
- the first clad 806 will typically have a large numerical aperture, making it ideal for light collection.
- the second clad 808 insure proper waveguide behavior for the first clad 806 . This approach would benefit especially the OCT technique as the separation between core and first cladding would probably be too low for efficient implementation of the spectral absorption technique.
- FIG. 13 shows a spectral absorption-based IAN sensor apparatus 900 that uses an entirely separate pulse oxymeter 902 operatively connected to a finger 904 of the patient as a monitor of blood oxygenation variations over the course of the drilling procedure, to maintain an inline calibration of the arterial blood absorption properties.
- this embodiment enables to compensate variations of blood optical properties from the oxygenation levels variation ( ā SatO2) to provide more accurate distance measurements, by updating the device calibration factors in real-time. Indeed, large variations in the optical properties will skew the sensor distance measurement. That being said, normal individuals will generally not see variations in blood oxygenation larger than ā 2%, which might well be within the error bar of the distance measurement.
- FIG. 14 shows a IAN sensor 1000 using a conical scanning principle that uses the drill rotation and a beveled double-clad optical waveguide 1002 that rotates with the drill 1004 in such a way that the source and collection channels would observe the tissues in front of the drill tip slightly off-axis.
- this is an alternative implementation to the standard B-mode scanning technique that operates along a line in the transverse plane.
- the drill rotation would allow a ring in the transverse plane to be scanned along the light propagation axis, essentially probing a conical surface within the jaw.
- the IAN bundle would intersect this conical surface at two opposite locations.
- the signal processor (not shown) of the device 1000 could then create an image 1006 by "unfolding" the conical surface on a computer screen 1008 , giving the dental surgeon a high resolution image similar to an ultrasonogram in real-time.
- the advantage of this B-mode scanning method is that the IAN bundle orientation in the transverse plane relative to the drill axis can be arbitrary. In the other implementations described, the IAN bundle should lie on the drilling axis, or the axis of the forward looking probe, to be detected properly. Otherwise the drill bit might pass beside the nerve and still produce damage, because the sensor did not "seeā the IAN bundle. Note that with the NIR spectral absorption technique, this flaw is fairly reduced due to the volume averaging effect mentioned earlier.
- Doppler OCT in the probe and use tissue changes or movement as a contrast mechanism:
- this configuration uses the Doppler effect to lock on blood flow.
- Doppler OCT is generally used to measure quantitatively microvasculature blood flow. In the case of this sensor, a qualitative measurement is enough to locate the IAN bundle. As such, the implementation of Doppler measurements in the OCT device would be simpler and cheaper.
- Experiments were conducted with Doppler OCT on an ex vivo human jawbone piece from which the neurovascular bundle was removed and a tube containing a flowing scattering fluid was connected, imitating blood flow in the canal. Results have shown that using the Doppler Effect as part of the spectral absorption technique might benefit the device.
- OCT data processing that utilizes changes or movement in the tissue like Doppler OCT, namely speckle variance OCT [Refs: A. Mariampillai et al., Opt. Lett. 33(13), 1530 (2008 ) ; A. Mariampillai et al., Opt. Lett. 35(8), 1257 (2010 )], can be used to embody the sensor. It proceeds as follow: first, a series of B-mode images of the same sample section over time is acquired. Second, for each pixel location the average value and variance are computed using pixel value of all images at that same exact location. This process leads to two 2D images. The first one is made with the pixel average value.
- non-zero pixels in that image are those associated with a stationary/non-moving part of the sample.
- the second image is made with the pixel variance values.
- non-zero pixels in that image are associated with the moving/spatially-varying part of the sample.
- this kind of processing will lead to contrast generation between hard and soft tissues in movement, or contrast based on tissue "viscosityā. Results have shown that the fluid may be identified from the variance image, contrasting with the bone section. This method could potentially make good usage of blood flow in the neurovascular bundle.
- a vascular contrast agent such as Indocyanine Green which is a NIR fluorescent dye approved for clinical use in a number of indications, can be used to enhance the signal coming from the artery in the IAN bundle. Injection of a bolus of ICG into the systemic circulation will momentarily make the artery in the IAN bundle fluoresce at 830 nm (when excited at 780 nm) against a non-fluorescent background, increasing the overall contrast dramatically. If tuned to the fluorescent wavelength, the spectral absorption sensor technique will have a much easier time at spotting the IAN bundle. The modulated excitation would equally translate to a modulated fluorescence signal. A difficulty is however that the device needs to be calibrated at two wavelengths (780 and 830 nm) instead of one. This can be solved by adding a second light source and operating in the same manner as described above for calibration at the two wavelengths, before the ICG injection.
- Biocompatible optical clearing agents such as fructose, glycerol, propylene glycol, glucose or mannitol solutions can partially replace the interstitial fluid due to hyperosmotic properties and provide a refractive index matching medium that reduces scattering due to a number of cell structures and organelles, thus increasing the transparency of the tissues to optical wavelengths and improving the depth penetration.
- FIG. 15A shows a drill-integrated IAN sensor 1100 rotating with the drill bit 1102 and using an optical fiber rotary joint 1104 for coupling the optical fibers in the drill head.
- FIG. 15B illustrates another alternative drill integrated IAN sensor 1150 wherein a rod-like optical waveguide 1152 is built as an integral part of the drill bit 1154 with a non-contact optical coupler 1156 from the optical fibers 1158 coming from the back-end in the drill head.
- a rod-like optical waveguide 1152 is built as an integral part of the drill bit 1154 with a non-contact optical coupler 1156 from the optical fibers 1158 coming from the back-end in the drill head.
- the probe design have circular symmetry, which is not achievable with a two-fiber design as the one shown in FIG. 10A .
- the handpiece should remain stationary with the drill bit rotating around the sensing assembly, as previously detailed.
- the tip of the drill bit may be plugged with a hard and transparent material (not shown), so it can withstand the large frictions of the drilling process while allowing light to pass through.
- Diamond or zirconium crystals would potentially be the best materials, due to their exceptional hardness and transparency in the visible and NIR spectral window but the skilled addressee will appreciate that other arrangements may be considered.
- the described invention could also be used in other fields of surgery where proximity to a neurovascular bundle embedded in hard tissues, such as bone, must be assessed during a surgical activity such as drilling or cutting. It can also be used to identify the presence of voids inside tissue structures, such as sinus cavities in the cranial anatomy, during drilling procedures.
- a LCI / OCT-based probe could also be envisioned as a bone mapping tool in oral surgery to determine the gums thickness at specific locations, as long as the device detection range is sufficient.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Description
- This application claims priority of
and entitled "METHOD AND SYSTEM FOR OPTICALLY EVALUATING PROXIMITY TO THE INFERIOR ALVEOLAR NERVE IN SITU" and ofUS Provisional Patent Application serial number 61/477,787 filed on April 21, 2011 and entitled "METHOD AND SYSTEM FOR OPTICALLY EVALUATING PROXIMITY TO THE INFERIOR ALVEOLAR NERVE IN SITU".US Patent Application serial number 13/329,557 filed on December 19, 2011 - The invention relates to methods and systems for evaluating proximity to a target, more specifically, for evaluating proximity to a nerve.
- Dental implants are a widely accepted treatment for the partially or completely edentulous patient. Dental implants are the fastest growing procedure in dentistry today. It is a 1 billion dollar industry in the USA. Dental implants offer a suitable alternative to mucosal adhering dentures and allow a more natural option for the patient. Implants have a high success rate when given proper care and when post-surgical instructions are followed. Dental implants can be in the form of a single tooth replacement, or can replace a series or an entire set of teeth. The basic implant procedure involves drilling a channel in the mandible where an artificial root is surgically inserted. A dental prosthesis is then placed onto the frame of the artificial root. Within a few months of recovery, the patient should have a fully integrated and functional prosthesis.
- Implant procedures are not without complications. The goal of an implant procedure is to attain a successful level of osseointegration. Osseointegration is defined as the direct anchorage of an implant by the formation of bony tissue around the implant without the growth of fibrous tissue at the bone-implant interface. Implants surrounded with fibrous tissue show mobility when a load is applied. The successfully osseointegrated implant shows no mobility when loaded. Other major factors for the successful implant depend mainly on the type of jaw treated, the density of the bone, and the length of the implant. Implant length is the depth created by the surgeon upon drilling a channel in the mandible. Short implants have a length of less than 10 mm and are noted to have larger failure rates. Hence the need to create sufficient length for successful osseointegration of implants within the mandible is a priority.
- However, the drilling of a large implant channel within the mandible carries a risk of breaching an intraosseous canal which encloses the inferior alveolar nerve (IAN). Disruption of the IAN can lead to loss of sensation in the anterior mandible area, such as paresthesia or numbness to the lower lip, due to the disruption of the mental nerve, which is the terminal branch of the IAN and is the neural bundle serving this area. The loss of sensation for the patient is certainly undesirable.
- The reported incidence of nerve injury from implant placement in the literature is highly variable and ranges depending on the study from 0% to as high as 44% (Misch and Resnik Implant Dentistry 2010; 19:378-386). A survey at the Misch international institute indicated that 73% of dentists have encountered neurosensory impairment within their practice. To help prevent nerve injury, patients can be subjected to CT scans which are costly and also involve radiation. The standard error for a CT scan is still in the range of 1.7 mm. This measurement error can result in nerve damage.
- There is thus a need to develop a surgical drill which is able to detect the proximity and/or location of the IAN in the mandible, preferably during implant procedures. The sensor device should allow the drill to approach closely, but not impair or damage the IAN within an acceptable error limit of the intraosseous canal. Hence, a system that automatically terminates drill action when in close range of the IAN would be most desirable.
- Document
US 2006/0285635 A1 relates to contrast enhanced spectroscopic optical coherence tomography. - Document
US 6,419,484 B1 pertains to an optical coherence tomography guided dental drill. - According to the present invention, there is provided a spectral absorption probe system according to
claim 1. Preferred embodiments are detailed in the dependent claims. - Having thus generally described the nature of the invention, reference will now be made to the accompanying drawings, showing by way of illustration a preferred embodiment thereof and in which:
-
FIG. 1 is a sagittal section of a mandible showing the inferior alveolar nerve (IAN) positioned directly underneath the molar teeth; -
FIG. 2 is a sagittal section of the inferior alveolar nerve (IAN) positioned at the bottom of the mandible; -
FIG. 3 (Prior Art) is a diagram of a standard time-domain Optical Coherence Tomography setup of the prior art; -
FIG. 4A (Prior Art) is a diagram of a spatially-encoded Fourier-domain OCT system (SEFD-OCT); -
FIG. 4B (Prior Art) is a diagram of a frequency-swept-source-based OCT system, or time-encoded Fourier-Domain OCT system (TEFD-OCT); -
FIG. 5 is a schematics of a low coherence interferometry probe system for evaluating proximity to a tissue layer, according to one embodiment. -
FIG. 6 is a concept schematics of a drill-integrated IAN sensor based on the NIR spectral absorption technique, according to one embodiment; -
FIG. 7 is a schematics of a spectral absorption probe system for evaluating proximity to an artery, according to one embodiment. -
FIG. 8 is a graph illustrating impact of propagation in a turbid medium such as biological tissue on an intensity-modulated light beam; -
FIG. 9 is a schematics of a heterodyne detection configuration for a IAN sensor, according to one embodiment; -
FIG. 10A is a schematics of an embodiment of a standalone IAN proximity sensor handpiece, according to a spectral absorption configuration; -
FIG. 10B is a schematics of another embodiment of a standalone IAN proximity sensor handpiece, according to a OCT-based, single fiber configuration; -
FIG. 11 is a schematics showing a disjointed spectral absorption IAN sensor configuration, according to one embodiment; -
FIG. 12 is a diagram of a double-clad optical fiber-based IAN sensor handpiece design, according to one embodiment; -
FIG. 13 is a diagram of a spectral absorption-based IAN sensor apparatus where a pulse oxymeter is used, according to one embodiment; -
FIG. 14 is a schematics of another IAN sensor using a conical scanning principle, according to another embodiment; -
FIG. 15A is a diagram of a drill-integrated IAN sensor using an optical fiber rotary joint, according to one embodiment; -
FIG. 15B is a diagram of a drill-integrated IAN sensor using a non-contact optical coupling, according to another embodiment; -
FIG. 16 is a diagram of a one dimensional model of a trabecular bone, according to one embodiment. -
FIG. 17 is a flow chart of a probe method for evaluating proximity to a tissue layer, according to one embodiment. -
FIG. 18 is a flow chart of a probe method for evaluating proximity to an artery, according to one embodiment. - It will be noted that throughout the appended drawings, like features are identified by like reference numerals.
- Referring to
FIGS. 1 and2 which show Sagittal sections of amandible 10, the inferior alveolar nerve 12 (IAN) is a branch of the mandibular nerve, which stems from the trigeminal nerve system. TheIAN 12 enters an intraosseous canal through the mandibular foramen in the posterior portion of the mandible. The nerve continues its path within themandible 10 and then exits through the mental foramen. Throughout the length of the osseous canal, theIAN 12 is closely associated with the inferior alveolar artery and both structures are covered in a tough sheath of connective tissue. The diameter of the entire bundle varies between patients but averages at 2.53±0.29 mm [C.D. Morris et al., J. Oral Maxillo. Surg., 68:2833-2836, 2010]. - The intraosseous canal is a hollow channel and in most cases has borders with defined walls which may be consistent throughout the length of the canal. The diameter of this canal is known to be 2.0 to 2.6 mm. The canal walls may either be composed of cortical bone, or in lesser frequency, may be continuous and uniform with the surrounding trabecular bone. Many patients have canals which abruptly become uniform and continuous with surrounding cancellous bone within proximity of the mental foramen. Although the intraosseous canal is present in many patients, it is not a consistent feature within the mandibles of every individual. Dissection studies show that cortical walls and distinct osseous canals within mandibles are not always present. Some specimens of IAN were shown to travel the trabecular marrow spaces without any defined canal present.
- The position of the
IAN 12 within themandible 10 is highly variable. In one dissection study, the position of the IAN varied in position from the sub-dental portion below the molar roots (SeeFIG. 1 ), to an inferior position near the bottom ridge of the mandible 10 (SeeFIG. 2 ). A feature which was not frequent, but was observed, was the splitting of the IAN bundle into diffuse branches without a defined intraosseous canal. - The general imaging methods currently used by surgeons to assess the position of the IAN are Panoramic X-ray, Computed Tomography (CT) scan, and Microradiograph (MR) imaging. As some patients may lack an osseous canal and an IAN bundle altogether, preoperative imaging is imperative. X-rays are usually taken in a panoramic fashion, encircling the entire mandible. This presents a global view of the mandible and images potential implant placement sites. The limitations of this technique are that it provides no information about mandible thickness and suffers from a distortion factor of about 25%. A more modern approach to the imaging of the mandible is the CT scan. This method is able to generate overlapping images through computer software programs. However, for dental surgical purposes, only bone and calcified structures are imaged by CT; the IAN and associated non-osseous tissues are not. Thus the CT scan is limited for patients without defined canal walls; locating the IAN on a single cross section is difficult. Reformatted images of adjacent parallel and perpendicular images must be taken and used to assess the exact relative location of the IAN within the mandible. Detailed X-ray imaging, or Mircoradiograph (MR) imaging, is able to image and provide a notable contrast between osseous and non-osseous tissues. When using MR, the canal is visible in cross-sectional reformations exclusive of the osseous tissue surrounding it. The drawback to using MR imaging is that spatial distortions on MR images may not give proper resolution for smaller distances. This is also true for both CT and Panoramic scans, although the resolution for both these techniques has been shown to be similar. Current CT based technologies are expanding imaging possibilities by integrating novel software and 3-D imaging methods.
- The drawback for all these imaging methods, with the exception of novel 3-D CT scanning methods, is that they are not in real time and must be performed preoperatively before the surgical procedure. These methods are also limited in resolution (typ. ±1.3mm) and may not be able to properly image diffuse IAN layouts for patients without a localized IAN bundle. This adds much uncertainty and leaves the surgeon to estimate the exact locations of the IAN during surgery. Thus, a technology which combines both the procedures of drilling and localization of the IAN into a simultaneous process has yet to be developed.
- In the process of dental implants, drilling is used to create channels within the mandible for the placement of artificial roots.
- The drilling operation performed on the mandible must traverse a cortical bone layer and into a cancellous bone mass. As the drill continues forward, heat is generated at the apex of the drill bit. Some of this heat is absorbed by the surrounding bone, raising its temperature. An implication of temperature rise and heat generation from machining bone is thermal osteonecrosis. Irreversible thermal osteonecrosis occurs when bone temperature reaches and exceeds 47°C. With irreversible osteonecrosis, adequate osseointegration could be inhibited, thus reducing the chances for a successful implant. When drilling bone without external irrigation, tissue temperatures can range from 31-56°C. An irrigation system is included in most surgical drills for this purpose. Water is injected through an orifice from the apex of the drill bit into the immediate drilling site. This acts to cool the drilling site, and functions to prevent thermal osteonecrosis. For the contribution of heat generation from the drill itself, the most important parameters are drill speed, feed rate and drill diameter. Hence with irrigation, adjustment and control of these parameters can help to reduce heat generation when drilling in bone.
- Currently, drill sensor technology is not aimed at discerning the media situated at the drill-bone interface. Technology is more focused on detecting and imaging wear on drill burs and machinery. There exists drill detection systems aimed at bone machining applications. A mechatronic system developed by Bouazza-Marouf and Ong [Ong, F.R., Bouazza-Marouf, K.; 1999; The detection of drill bit break-through for the enhancement of safety in mechatronic assisted orthopaedic drilling; MECHATRONICS 9: 565-588] is able to discern drill break-through from inherent fluctuations in bone structure when drilling long bones. This system is able to detect differences in force through an electronic logic algorithm. The drawback here is that a certain, constant force is applied and the drill bit feed rate into the bone media is constant. In practice, drilling with constant force and feed rate would not be used due to variability in bony tissues within the body and between patients. The mechatronic system was also not able to discern latent non-osseous tissue. The application of this system for the purpose of long implant placement within the mandible would not be desirable as bone breakthrough is the arresting factor for this system.
- Current surgery practice allows for an experienced dental surgeon to drill the mandible down to a distance of 2 mm from the IAN, without too much risk of damaging the nerve bundle. As such, the proximity sensor operating range should be within this 2 mm boundary, although a longer distance of operation would be useful. At the same time, the axial resolution of the sensor should be as high as possible.
- The first approach is based on Low Coherence Interferometry (LCI). A LCI probe can be built to operate in A-mode (i.e. point-scan only, no image). LCI presents similar results to ultrasound echolocation and provides a high-resolution measurement of the tissue layers structure based on back-scattered light intensity from those layers. The measurements being optical in nature, the axial resolution of this technique is at least ten times better than with ultrasound, at the cost of a much lower depth penetration (typ. resolutions in ā¼10 µm at maximal depths of ā¼1.5 mm, depending on tissues optical absorption and scattering properties). The particular imaging extension of this technique, i.e B-mode scanning, is known in the art as Optical Coherence Tomography (OCT).
-
FIG. 3 shows an embodiment of a standard time-domain LCI orOCT system 30 using a low coherence light source 32 (typically a superluminescent LED or pulsed laser) and an interferometer configuration 34 for performing alongitudinal scanning 36 and alateral scanning 38. As illustrated, anoptical arrangement 40 is used for implementing thelateral scanning 38 while an optical arrangement 42 comprising a movingmirror 44 is used for implementing thelongitudinal scanning 36. Asignal processor 46 may be used in conjunction with acomputer 48 for signal processing purposes. Newer designs, as the 50 and 52 shown insystems FIGS. 4A and 4B respectively, involve detecting in the Fourier domain or using frequency-swept light sources to disband with the traditional time-pulsed requirement of the incident light emission. Thesystem 50 comprises a low coherence source (LCS) 54, aninterferometer sub-assembly 56 provided with a beamsplitter (BS) 58 and a reference mirror (REF) 60. Thesystem 50 also comprises a diffraction grating (DG) 62 and a camera (CAM) 64 for detecting light back-scattered by the sample (SMP) 66. A digital signal processor (DSP) 68 is operatively connected to thecamera 64 for providing an OCT image based on the back-scattered light. Thesystem 52 ofFIG. 4B uses a swept source (SS) 72 in place of thelow coherence source 54 ofFIG. 4A and a photodetector (PD) 70. - An A-Mode fibered LCI probe can be designed in a compact form small enough to fit within a dental drill bit, according to one embodiment. Tissue interfaces will appear as an increase in the back-scattered signal intensity. Similarly, in an alternative embodiment, a B-mode 2D image can be generated by building the LCI / OCT probe with an integrated forward-looking proximal or distal scanner, as it should become apparent to the skilled addressee. In the case of the IAN, an interface signal will be generated either by the canal wall or the nerve bundle itself and will be visible in real time to the dental surgeon as long as the interface is within the penetration depth range of the instrument.
-
FIG. 5 illustrates a low coherenceinterferometry probe system 100 for evaluating proximity to atissue layer 102, according to the above detailed technique and according to one embodiment. Theprobe system 100 comprises a low coherencelight source 104 for generating lowcoherence excitation light 106, an excitationoptical fiber 108 to bring the lowcoherence excitation light 106 near thetissue layer 102 and a collectionoptical fiber 110 for capturing back-scattered light from thetissue layer 102. Theprobe system 100 also comprises a lowcoherence interferometry sub-system 112 operatively connected to the excitationoptical fiber 108 and the collectionoptical fiber 110 and having abeam splitter 114 and areference mirror 116. Adigital signal processor 118 operatively connected to the lowcoherence interferometry sub-system 112 is used for evaluating adistance 120 to thetissue layer 102 based on the back-scattered light received by the collectionoptical fiber 110. -
FIG. 17 illustrates a low coherence interferometry probe method for evaluating proximity to a tissue layer, according to one embodiment. According to processingstep 1710, a low coherence excitation light is generated. According to processingstep 1720, the low coherence excitation light is brought near the tissue layer. According tostep 1730, back-scattered light from the tissue layer is captured. According to processingstep 1740, interferometry between the low coherence excitation light and the back-scattered light is performed for providing an interference signal. According to processingstep 1750, the interference signal is processed for evaluating a distance to the tissue layer. - Experiments were conducted with a
probe system 100 on a post-mortem extracted human jawbone cut in such a way that the LCI entry point surface made a wedge with the approximate location of the canal, thus providing increased depth of the IAN interface with the entry point location. This approach allows to evaluate the depth penetration of the technique. The results indicate a probing range of about 1 mm within the test conditions (ex vivo sample, wavelength of 1.32 µm). An increase in wavelength should improve detection range as tissue scattering decrease monotonically with wavelength. However, one must also fine tune the wavelength so that it fits between tissue absorption lines that are numerous in these ranges due to tissue water content. Appropriate designs for performing LCI / OCT systems seem to favor the use of frequency-swept laser sources for state-of-the-art devices. Availability of such light sources at 1.55 µm is increasing and development at 1.8 µm is ongoing. The skilled addressee will nevertheless appreciate that other arrangements may be considered. - A second optical approach is to use the spectral absorption properties of arterial blood and the blood flow dynamics (change in blood volume due to the patient's pulse) to measure the distance to this artery based on the Beer-Lambert law of light absorption:
where I and I0 are the detected and incident light intensities, respectively, d is the total propagation distance of the light within tissues (the sensor will measure the distance s = d/2) and µ eff is the attenuation coefficient of the medium in which light propagation occurs. In the case of tissues, attenuation is a combination of absorption and scattering of the photons at the illumination wavelength and is tissue-type-dependent. - A first approximation model can provide an evaluation of the order of magnitude of the return signal. The probing device would operate from within the trabecular bone to identify the artery from the IAN neurovascular bundle. Trabecular bone is a complex structure composed of cortical bone and bone marrow arranged in "cells", similar to a beehive. Optically, this structure may be represented in a one
dimensional model 200 where three 202, 204, 206 are stacked vertically, each representing cortical bone, bone marrow and arterial blood, as illustrated inlayers FIG. 16 . In this model, the blood layer thickness varies over time in a periodic fashion to represent the blood volume change in the arteries due to the cardiac cycle. The thickness of the bone and marrow layers is dependent on the porosity of the trabecular structure. -
- where µx and dx (x = marrow, cortical, HbO2) are the attenuation coefficient and layer thickness of each of the three types of tissue involved. The marrow and cortical layer thicknesses are related to the porosity of the
trabecular structure 0 < p <1 such that:
where dtotal = dmarrow + dcortical is the total thickness of trabecular bone between the light input and the arterial layer. Because of blood flow and its properties, the HbO2 terms are time-dependent. Indeed, the distance parameter dHbO2 will change due to the volume variation occurring with pulsating blood flow. In the proposedmodel 200, this is represented by a harmonic variation of the thickness of the arterial layer:
where dHbO2-baseline is the average thickness of the layer, 0 < Īd < 1 is the maximum fractional thickness change due to pulsating blood flow, t is time and f is the blood pulse frequency in Hz. - The HbO2 attenuation coefficient should also be considered a time-dependent value as it is related to blood oxygenation levels in the patient, thus dependent on the proportions of oxy- and deoxy-hemoglobin in arterial blood. In practice, however, the variation of blood oxygenation will generally be on a much longer time scale than the variations due to the patient's pulse. Strong and sudden variations of blood oxygenation are rare and indicative of a serious health condition that is unlikely to be encountered in the normal operation of the IAN sensor. Nevertheless, monitoring of blood oxygenation with a pulse oxymeter is considered a good practice in the utilization of such a sensor, if only as a check point for the sensor's calibration, as detailed below. For the sake of the proposed model, the attenuation coefficient was however assumed to be a constant.
-
- The near infrared spectroscopy (NIRS) based sensor goal is to measure the thickness dtotal of trabecular bone tissue between the probe (or drill) tip and the neurovascular bundle containing the IAN. In one embodiment, a lock-in amplifier may be used to establish the magnitude of the oscillating signal and circumvent the DC signal that is influenced by the static trabecular tissue, as detailed below. In one embodiment, a typical method is to use the root-mean square value of the AC signal:
where: -
-
- With such a model, assuming an input of 10 mW of optical power at the proper wavelength, an output signal of approximately 0.07 mW would be produced.
-
FIG. 7 shows a spectralabsorption probe system 300 for evaluating proximity to anartery 302, according to the above detailed technique and according to one embodiment. Theprobe system 300 comprises alight source 304 for generatingexcitation light 306 having a wavelength adapted for absorption by blood chromophores, an excitationoptical fiber 308 to bring theexcitation light 306 near theartery 302 and a collectionoptical fiber 310 for capturing back-scattered light from theartery 302. Theprobe system 300 comprises alight detector 312 operatively connected to the collectionoptical fiber 310 and asignal processor 314 operatively connected to thelight detector 312 for determining adistance 320 to theartery 302 based on the back-scattered light and on Beer-Lambert law of light absorption using a value for surrounding tissue attenuation coefficient (µeff). -
FIG. 18 illustrates a spectral absorption probe method for evaluating proximity to an artery, according to one embodiment. According to processingstep 1810, an excitation light having a wavelength adapted for absorption by blood chromophores is generated. According to processingstep 1820, the excitation light is brought near the artery. According to processingstep 1830, back-scattered light is captured from the artery. According to processingstep 1840, the back-scattered light from the artery is processed for determining a distance to the artery based on Beer-Lambert law of light absorption using a value for surrounding tissue attenuation coefficient (µeff). - As anatomically the artery is part of the IAN bundle, locating it is almost equivalent to locating the nerve. This approach can be implemented in a similar package as the LCI / OCT fiber probe that can fit within the dental drill bit. The blood pulse can be used to eliminate all background signals via AC-coupling of the detector or lock-in amplification. The signal amplitude can then be used to assess the distance from the probe to the IAN bundle based on Beer-Lambert's law. A calibration process is however typically required before use in situ due to patient's tissues variability of optical properties. Notably, the approach relies on the absorption of oxyhemoglobin, which itself will potentially vary according to blood oxygen saturation. As such, the approach might benefit from the probe being used in conjunction with a pulse oxymeter that would monitor oxygen saturation levels and thus, indirectly account for variations of the blood attenuation coefficient. A variation on this approach uses the same spectral principle as the pulse oxymeter, utilizing two wavelengths (typically, 660 nm to target deoxyhemoglobin and 850 nm to target oxyhemoglobin, but generally comprised between 650 nm and 900 nm), as shown in
FIG. 6 which illustrates a drill-integratedIAN sensor 600 based on the NIR spectral absorption technique. As detailed therein, distance can be obtained by isolating the distance variable (d) in Equ. 1, but requires that the surrounding tissues' attenuation coefficient (µeff) be known through a calibration step. It has to be noted that such a technique would be limited in the precision of the measurement, as the signal output results from probing a large volume with diffused photons and is thus inherently averaging over that volume, which might skew the output value of distance. Using AC-coupling and a proper calibration is key in this approach, as detailed thereafter. - In one embodiment, the calibration for the spectral absorption technique may be integrated within the standard configuration if a lock-in amplifier (not shown) is used. In such an embodiment, as illustrated in
FIG. 8 , an intensity-modulated light excitation of modulation frequency f (typ. ā¼100 MHz range) and modulation depth M1 propagating in the tissues will suffer phase retardation and reduction of the modulation depth as a function of the attenuation properties of the traversed medium. The retrieved signal has the same frequency as the incident one, but due to absorption and scattering in the medium, it suffers a phase shift ĪΦ and an attenuation of the modulation depth M2 relative to the incident signal. The change in phase ĪΦ and modulation depth ĪM is correlated to the average attenuation coefficient and can be used to extract the parameter µeff in Equ. 1. This method is known in the art of Diffuse Optical Tomography. To achieve accurate results, though, the modulation frequency should be in the range of about 100 MHz to 500 MHz. Unfortunately, limitations in current lock-in amplifier electronics make most affordable conventional devices to operate up to the hundreds of kHz range. - This issue can be solved by using a heterodyning processing circuit before the lock-in amplifier input, as illustrated in
FIG. 9 , using signal mixing with an intermediate frequency and using principles of Amplitude Modulation to extract the difference signal. In the illustrated embodiment of aprobe system 400, thelight source 402 is driven at high frequency with alight source driver 404, for example at 200 MHz, to insure adequate resolution on the extracted values ĪΦ and ĪM. Alocal oscillator 406 generates a slightly larger frequency, larger by 50 kHz as a non-limitative example. Theoscillator 406 and thedriver 404 are phase-locked by aPLL circuit 408. Mixing those two signals produces the sum and difference signals (amplitude modulation) and a low-pass filter 410 is used to retain only the difference component. Thedetection channel 412 operates similarly and a standard, low-bandwidth dual-phase lock-inamplifier 414 can then be used. - Furthermore, it is known in the art that the positioning of the probe for calibration (in contact or not with tissues and other variants) can skew the calibration measurement. The method might thus need an additional step where the instrument is pre-calibrated with an appropriate optical phantom (not shown) with known attenuation properties supplied with the device, before the in-patient calibration step. This way, a relative value to the phantom properties would be obtained and should be enough for the proper operation of the sensor.
- With such an approach, the calibration of the device for the patient's jaw tissues may be made at the beginning or at an early phase of the drilling process by the surgeon, before enabling the sensor, which is of great advantage.
- Different embodiments of the Optical IAN probe system can be envisioned for both approaches described above. The following is a short description of each of the potential embodiments and implementations envisioned:
- Standalone self-contained spectral absorption-based fiber-probe:
FIG. 10A shows an embodiment wherein the sensor is built as a standalonefiber optic device 500 contained within a biocompatiblemetallic rod 502. Therod 502 contains twooptical fibers 504, 506 (single- or multimode) along its axial direction. One fiber serves to bring the excitation light within the tissues while the other captures the back-scattered light. 504, 506 run parallel to each other and are separated by an adequate distance (1-2 mm) to fit into the hole bored by the dental drill bit (typ. 2 mm dia.). The skilled addressee will appreciate that the separation between the twoFibers 504, 506 should be as large as possible to maximize penetration depth. Indeed, in back-reflected diffuse optical sensing, the depth of penetration is increased with source-detector separation. The skilled addressee will also appreciate that multimode fibers may be employed to increase light throughput in both channels. In this embodiment, the fiber probe itself is connected to the device back-end. As previously mentioned, the excitation fiber is connected to a light source (either LED, laser or other source) or multiple light sources each having an appropriate wavelength for optimized absorption by blood chromophores (mainly oxy- and deoxyhemoglobin). Typical wavelengths are around 660 nm and 850 nm. The light source output could be modulated at a reference frequency in the kHz range. The collection fiber is connected to an appropriate light detector such as a photodiode, an avalanche photodiode (APD), a photomultiplier tube (PMT), a camera or the like. The detector output signal is either AC-coupled or connected to a lock-in amplifier operating at the same reference frequency as the light source modulation. The goal of the modulation signal or the AC-coupling is to reject background signals coming from other tissues than the flowing arterial blood. A variation of this embodiment makes use of a varying input optical power into the tissue to establish the neurovascular bundle position relative to the probe based on an intensity threshold approach, where larger input powers will statistically increase linearly the number of photons reaching larger depths, thus improving the chance of detecting some of these photons that might probe the neurovascular bundle.fibers - Standalone self-contained low coherence interferometry-based fiber-probe:
FIG. 10B shows another embodiment similar to the one shown inFIG. 10A in shape but implementing the OCT approach. As illustrated, asingle fiber 508 can be used for illumination and collection purposes. Due to the difference in requirements between OCT and the spectral absorption concept, the fiber probe should be made of one or multiple single-mode optical fibers to prevent detrimental dispersion and spatial propagation modes mixing, according to one embodiment. The back-end of the probe utilizes classical OCT configurations, such as time-domain-based, frequency-domain OCT or swept-source-based implementations, as previously detailed. In this embodiment, the back-end is entirely fiberized and uses fiber couplers to connect with the probe itself, as is well-known in the art. In a further embodiment, the probe forward-looking configuration can be implemented for B-mode scanning, by integrating a proximal scanning system installed in the back-end coupled to a bundle of single mode optical fibers, or through a distal scanning mechanism integrated into the probe head itself that would use one single-mode optical fiber. - Drill-integrated probe: Referring again to
FIG. 6 , any of the described embodiments can be integrated at the center of thedrill bit 610 of a dental surgery drill. The center of adental drill bit 610 can have ahollow core 602 to allow for cooling water to circulate down to the drilling site 604. The fiber probe can be inserted within thishollow core 602. - Combined OCT / Spectral absorption probe: Such a combined configuration uses the advantages of each approach. The spectral absorption approach has potentially a greater detection range, while the OCT approach is more straightforward and offer potentially better resolution at short range. A combined sensor probe could thus potentially identify roughly the position of the IAN bundle at a distance with the spectral absorption mode and then switch to an OCT approach when close to the IAN (typ. within 1.5 mm). The sensor construction would require two or three optical fibers grouped in a bundle. A single-mode fiber would bring the excitation light. A second single-mode fiber would be used for OCT light collection, while a third multimode fiber would be used for the spectral absorption mode light collection channel. Alternatively, the single-mode excitation fiber could double-up as the collection fiber for the OCT technique.
- Spectral absorption fiber probe with disjointed source and collection channels:
FIG. 11 shows an embodiment of a disjointed spectralabsorption IAN sensor 700. In this configuration of the spectral absorption technique, one or multiple excitationoptical fibers 702 are positioned on the side of the gum orjawbone 704, outside of theprobe handpiece 706 itself (or the drill bit), while the detection optical fiber 708 is still integrated in theprobe handpiece 706, within thedrilling hole 710 in thebone 704. Such a configuration allows larger separation of the source and collection channels, which will increase depth sensitivity of the technique. Indeed, as previously mentioned, in back-reflected diffuse optical sensing, the depth of penetration is increased with source-detector separation. Alternatively, the source and collection channels can be reversed, with the detection being done laterally on the gum and the illumination being integrated in the drill bit, or probe handpiece. In a further embodiment, using multiple optical fibers built in a linear array may provide refined measurements of the neurovascular bundle's position in the jaw. - Use of a double-clad optical fiber:
FIG. 12 illustrates a double-clad optical fiber-basedIAN sensor handpiece 800 which may be used alternatively to the use of two optical fibers in the probe. Thecore 802 of the double-cladoptical fiber 804 is used as the excitation channel to send light into tissues and thefirst cladding 806 acts as the collection channel. In the OCT approach and in one embodiment, thecore 802 is built for single mode propagation. The first clad 806 will typically have a large numerical aperture, making it ideal for light collection. The second clad 808 insure proper waveguide behavior for the first clad 806. This approach would benefit especially the OCT technique as the separation between core and first cladding would probably be too low for efficient implementation of the spectral absorption technique. - Combining the spectral absorption probe with a pulse oxymeter in the technique:
FIG. 13 shows a spectral absorption-basedIAN sensor apparatus 900 that uses an entirelyseparate pulse oxymeter 902 operatively connected to afinger 904 of the patient as a monitor of blood oxygenation variations over the course of the drilling procedure, to maintain an inline calibration of the arterial blood absorption properties. In other words, this embodiment enables to compensate variations of blood optical properties from the oxygenation levels variation (ĪSatO2) to provide more accurate distance measurements, by updating the device calibration factors in real-time. Indeed, large variations in the optical properties will skew the sensor distance measurement. That being said, normal individuals will generally not see variations in blood oxygenation larger than ā¼2%, which might well be within the error bar of the distance measurement. - Developing a B-mode OCT technique using the drill rotation for scanning:
FIG. 14 shows aIAN sensor 1000 using a conical scanning principle that uses the drill rotation and a beveled double-cladoptical waveguide 1002 that rotates with thedrill 1004 in such a way that the source and collection channels would observe the tissues in front of the drill tip slightly off-axis. As it should become apparent to the skilled addressee, this is an alternative implementation to the standard B-mode scanning technique that operates along a line in the transverse plane. The drill rotation would allow a ring in the transverse plane to be scanned along the light propagation axis, essentially probing a conical surface within the jaw. The IAN bundle would intersect this conical surface at two opposite locations. The signal processor (not shown) of thedevice 1000 could then create animage 1006 by "unfolding" the conical surface on acomputer screen 1008, giving the dental surgeon a high resolution image similar to an ultrasonogram in real-time. The advantage of this B-mode scanning method is that the IAN bundle orientation in the transverse plane relative to the drill axis can be arbitrary. In the other implementations described, the IAN bundle should lie on the drilling axis, or the axis of the forward looking probe, to be detected properly. Otherwise the drill bit might pass beside the nerve and still produce damage, because the sensor did not "see" the IAN bundle. Note that with the NIR spectral absorption technique, this flaw is fairly reduced due to the volume averaging effect mentioned earlier. - Implement Doppler OCT in the probe and use tissue changes or movement as a contrast mechanism: In addition to using standard OCT in the sensor, this configuration uses the Doppler effect to lock on blood flow. Doppler OCT is generally used to measure quantitatively microvasculature blood flow. In the case of this sensor, a qualitative measurement is enough to locate the IAN bundle. As such, the implementation of Doppler measurements in the OCT device would be simpler and cheaper. Experiments were conducted with Doppler OCT on an ex vivo human jawbone piece from which the neurovascular bundle was removed and a tube containing a flowing scattering fluid was connected, imitating blood flow in the canal. Results have shown that using the Doppler Effect as part of the spectral absorption technique might benefit the device.
- According to another embodiment, another variant of OCT data processing that utilizes changes or movement in the tissue like Doppler OCT, namely speckle variance OCT [Refs: A. Mariampillai et al., Opt. Lett. 33(13), 1530 (2008) ; A. Mariampillai et al., Opt. Lett. 35(8), 1257 (2010)], can be used to embody the sensor. It proceeds as follow: first, a series of B-mode images of the same sample section over time is acquired. Second, for each pixel location the average value and variance are computed using pixel value of all images at that same exact location. This process leads to two 2D images. The first one is made with the pixel average value. Therefore, non-zero pixels in that image are those associated with a stationary/non-moving part of the sample. The second image is made with the pixel variance values. Thus, non-zero pixels in that image are associated with the moving/spatially-varying part of the sample. In a similar fashion to Doppler OCT, this kind of processing will lead to contrast generation between hard and soft tissues in movement, or contrast based on tissue "viscosity". Results have shown that the fluid may be identified from the variance image, contrasting with the bone section. This method could potentially make good usage of blood flow in the neurovascular bundle.
- Use of a non-specific vascular contrast agent to facilitate artery detection: A vascular contrast agent, such as Indocyanine Green which is a NIR fluorescent dye approved for clinical use in a number of indications, can be used to enhance the signal coming from the artery in the IAN bundle. Injection of a bolus of ICG into the systemic circulation will momentarily make the artery in the IAN bundle fluoresce at 830 nm (when excited at 780 nm) against a non-fluorescent background, increasing the overall contrast dramatically. If tuned to the fluorescent wavelength, the spectral absorption sensor technique will have a much easier time at spotting the IAN bundle. The modulated excitation would equally translate to a modulated fluorescence signal. A difficulty is however that the device needs to be calibrated at two wavelengths (780 and 830 nm) instead of one. This can be solved by adding a second light source and operating in the same manner as described above for calibration at the two wavelengths, before the ICG injection.
- In similar fashion, the various embodiments based on LCI / OCT can benefit from the potential application of optical clearing agents at the site of probing. Biocompatible optical clearing agents, such as fructose, glycerol, propylene glycol, glucose or mannitol solutions can partially replace the interstitial fluid due to hyperosmotic properties and provide a refractive index matching medium that reduces scattering due to a number of cell structures and organelles, thus increasing the transparency of the tissues to optical wavelengths and improving the depth penetration.
- Integration of the sensor into a drill bit presents a number of mechanical challenges, the most important ones being the rotation speed and how to protect the optical sensor at the drill tip, without blocking light injection and detection. Dental drills can rotate at rates up to 20,000 RPM. In typical use for dental implant surgery, the rotation speed will be in the range of 2,000 to 4,000 RPM.
- To fit within the hollow core of a drill bit, the optical fiber assembly should be secured in such a way that the optical fibers do not come into contact with the rotating inner wall. The friction at high rotating speeds would most certainly break the optical fibers. An alternative is to have the fiber assembly rotate with the drill bit, so that relative positioning of the fibers and the inner wall is stationary.
FIG. 15A shows a drill-integratedIAN sensor 1100 rotating with thedrill bit 1102 and using an optical fiber rotary joint 1104 for coupling the optical fibers in the drill head. -
FIG. 15B illustrates another alternative drill integratedIAN sensor 1150 wherein a rod-likeoptical waveguide 1152 is built as an integral part of thedrill bit 1154 with a non-contactoptical coupler 1156 from the optical fibers 1158 coming from the back-end in the drill head. The skilled addressee will note that having a rotating handpiece requires that the probe design have circular symmetry, which is not achievable with a two-fiber design as the one shown inFIG. 10A . In this last case, the handpiece should remain stationary with the drill bit rotating around the sensing assembly, as previously detailed. - In a further embodiment, in order to prevent introduction of organic tissues and debris within the hollow core that could clog it and prevent proper function of the sensor, the tip of the drill bit may be plugged with a hard and transparent material (not shown), so it can withstand the large frictions of the drilling process while allowing light to pass through. Diamond or zirconium crystals would potentially be the best materials, due to their exceptional hardness and transparency in the visible and NIR spectral window but the skilled addressee will appreciate that other arrangements may be considered.
- The described invention could also be used in other fields of surgery where proximity to a neurovascular bundle embedded in hard tissues, such as bone, must be assessed during a surgical activity such as drilling or cutting. It can also be used to identify the presence of voids inside tissue structures, such as sinus cavities in the cranial anatomy, during drilling procedures. As another example of application, a LCI / OCT-based probe could also be envisioned as a bone mapping tool in oral surgery to determine the gums thickness at specific locations, as long as the device detection range is sufficient.
- The embodiments described above are intended to be exemplary only. The scope of the invention is therefore intended to be limited solely by the appended claims.
Claims (15)
- A spectral absorption probe system (300) using the spectral absorption properties of arterial blood and the blood flow dynamics, that is the change in blood volume in an artery due to a patient's pulse, for evaluating proximity to the artery (302), comprising:a light source (304) for generating excitation light (306) having a wavelength adapted for absorption by blood chromophores;an excitation optical fiber (308) to bring said excitation light near the artery;a collection optical fiber (310) separated from the excitation optical fiber (308) for capturing back-scattered light from said artery;a light detector (312) operatively connected to said collection optical fiber; anda signal processor (314) operatively connected to said light detector for determining a distance (320) to said artery based on said back-scattered light and on Beer-Lambert law of light absorption using a time dependent value for surrounding tissue attenuation coefficient (µeff).
- The spectral absorption probe system (300) as claimed in claim 1, further comprising a biocompatible metallic rod (502) surrounding said excitation optical fiber and said collection optical fiber.
- The spectral absorption probe system (300) as claimed in claim 1, wherein said excitation optical fiber (308) and said collection optical fiber (310) are provided in a single double-clad optical fiber (804) with a fiber core (802) of said double-clad optical fiber bringing said excitation light near said artery and a first clad of said double-clad optical fiber capturing said back-scattered light from said artery.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 3, wherein said probe system is fibered and integrated within a hollow core (602) of a drill bit (610).
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 4, wherein an operating depth range of the probe system is comprised between 1 mm and 5 mm.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 5, wherein the light source (304) is selected from a group consisting of a LED, a laser and a set of light source units, wherein the wavelength of the light source is comprised between 650 nm and 900 nm.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 6, further comprising an additional light source having a wavelength adapted for absorption by blood chromophores, the wavelengths of the light source and of the additional light source being each comprised between 650 nm and 900 nm.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 7, wherein the light detector (312) is selected from a group consisting of a photodiode, an avalanche photodiode (APD), a photomultiplier tube (PMT) and a camera.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 8, further comprising a calibration unit having a pulse oxymeter (902) for monitoring oxygen saturation levels to maintain an inline calibration of arterial blood absorption properties.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 9, wherein said surrounding tissue attenuation coefficient (µeff) is determined according to absorption and scattering in surrounding tissue of a calibration excitation signal.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 10, wherein the signal processor (314) comprises a lock-in amplifier and a heterodyning processing circuit connected thereto and/or wherein the light detector (312) is AC-coupled to the signal processor.
- The spectral absorption probe system (300) as claimed in any one of the previous claims, wherein a single one of said excitation optical fiber (308) and said collection optical fiber (310) is integrated within a hollow core of a drill bit.
- The spectral absorption probe system (300) as claimed in any one of claims 1 to 12, wherein said light source (304) has low coherence, and further comprising:a low coherence interferometry sub-system (112) operatively connected to the excitation optical fiber and the collection optical fiber and having a beam splitter (114) and a reference mirror (116); anda signal processor (118) operatively connected to said low coherence interferometry sub-system for evaluating a distance to said artery based on said back-scattered light received by said collection optical fiber.
- The spectral absorption and low coherence interferometry probe system as claimed in claim 13, wherein the excitation optical fiber (308) comprises a single mode fiber and further wherein the collection optical fiber comprises a single mode fiber for OCT mode light collection and a multimode fiber for spectral absorption mode light collection.
- The spectral absorption and low coherence interferometry probe system as claimed in any one of claims 13 and 14, wherein the probe system comprises a forward-looking transverse scanner enabling B-mode imaging.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161477787P | 2011-04-21 | 2011-04-21 | |
| US13/329,557 US9179843B2 (en) | 2011-04-21 | 2011-12-19 | Method and system for optically evaluating proximity to the inferior alveolar nerve in situ |
| PCT/IB2012/050045 WO2012143798A1 (en) | 2011-04-21 | 2012-01-04 | Method and system for optically evaluating proximity to the inferior alveolar nerve in situ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP2699165A1 EP2699165A1 (en) | 2014-02-26 |
| EP2699165A4 EP2699165A4 (en) | 2014-07-09 |
| EP2699165B1 true EP2699165B1 (en) | 2017-06-07 |
Family
ID=47021862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12774529.7A Active EP2699165B1 (en) | 2011-04-21 | 2012-01-04 | System for optically evaluating proximity to the inferior alveolar nerve in situ |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9179843B2 (en) |
| EP (1) | EP2699165B1 (en) |
| CA (1) | CA2833432C (en) |
| DK (1) | DK2699165T3 (en) |
| ES (1) | ES2635539T3 (en) |
| WO (1) | WO2012143798A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240173039A1 (en) * | 2022-11-29 | 2024-05-30 | Metal Industries Research & Development Centre | Detection method for surgical drilling and end effector used therein |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070122344A1 (en) | 2005-09-02 | 2007-05-31 | University Of Rochester Medical Center Office Of Technology Transfer | Intraoperative determination of nerve location |
| US20080161744A1 (en) | 2006-09-07 | 2008-07-03 | University Of Rochester Medical Center | Pre-And Intra-Operative Localization of Penile Sentinel Nodes |
| US8406860B2 (en) | 2008-01-25 | 2013-03-26 | Novadaq Technologies Inc. | Method for evaluating blush in myocardial tissue |
| US10492671B2 (en) | 2009-05-08 | 2019-12-03 | Novadaq Technologies ULC | Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest |
| EP2863801B8 (en) | 2012-06-21 | 2024-06-12 | Stryker Corporation | Quantification and analysis of angiography and perfusion |
| IL221187A (en) | 2012-07-30 | 2017-01-31 | Adom Advanced Optical Tech Ltd | System for performing dual beam, two-dimensional optical coherence tomography (oct) |
| US9449377B2 (en) * | 2012-10-09 | 2016-09-20 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Imaging methods and computer-readable media |
| DK2941220T3 (en) | 2012-12-24 | 2022-02-07 | Dentlytec G P L Ltd | DEVICE AND METHOD OF SUBGINGIVAL MEASUREMENT |
| EP2762496A1 (en) * | 2013-02-05 | 2014-08-06 | EngMab AG | Method for the selection of antibodies against BCMA |
| EP2762497A1 (en) * | 2013-02-05 | 2014-08-06 | EngMab AG | Bispecific antibodies against CD3epsilon and BCMA |
| PL2953972T3 (en) * | 2013-02-05 | 2021-03-08 | Engmab SĆ rl | Method for the selection of antibodies against bcma |
| AU2015327665B2 (en) | 2014-09-29 | 2018-09-27 | Stryker European Operations Limited | Imaging a target fluorophore in a biological material in the presence of autofluorescence |
| AU2014408488B2 (en) * | 2014-10-09 | 2019-07-18 | Stryker European Operations Limited | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
| WO2016113745A1 (en) | 2015-01-18 | 2016-07-21 | Dentlytec G.P.L. Ltd | System, device, and method for dental intraoral scanning |
| US10966614B2 (en) | 2015-01-18 | 2021-04-06 | Dentlytec G.P.L. Ltd. | Intraoral scanner |
| US12259231B2 (en) | 2015-01-18 | 2025-03-25 | Dentlytec G.P.L. Ltd. | Intraoral scanner |
| DE212016000074U1 (en) | 2015-04-09 | 2018-01-02 | Bikanta Corp. | Imaging systems with fluorescent nanodiamonds |
| WO2016178212A1 (en) | 2015-05-01 | 2016-11-10 | Dentlytec G.P.L. Ltd | System, device and methods for dental digital impressions |
| IL239113A (en) | 2015-06-01 | 2016-12-29 | Elbit Systems Land & C4I Ltd | System and method for determining audio characteristics from within a body |
| US10571390B2 (en) * | 2015-12-21 | 2020-02-25 | The Boeing Company | Composite inspection |
| WO2017136773A1 (en) | 2016-02-04 | 2017-08-10 | Canon U.S.A., Inc. | Diffusing wave spectroscopy with heterodyne detection |
| EP3471627A4 (en) | 2016-06-16 | 2020-02-19 | Ark Surgical Ltd. | TISSUE CONTAINMENT DEVICE FOR USE IN SURGICAL INTERVENTIONS |
| US20210007673A1 (en) * | 2016-07-22 | 2021-01-14 | Northwestern University | Method and system for detecting contact between an optical probe and tissue and automating tissue measurement |
| US12285188B2 (en) | 2016-09-10 | 2025-04-29 | Ark Surgical Ltd. | Laparoscopic workspace device |
| WO2018047180A1 (en) | 2016-09-10 | 2018-03-15 | Ark Surgical Ltd. | Laparoscopic workspace device |
| CN106618766B (en) * | 2016-12-29 | 2019-09-24 | ä½å±±ē§å¦ęęÆå¦é¢ | A kind of optical fiber plantation bender |
| WO2018145193A1 (en) | 2017-02-10 | 2018-08-16 | Novadaq Technologies ULC | Open-field handheld fluorescence imaging systems and methods |
| CN107242850B (en) * | 2017-05-09 | 2020-02-21 | åäŗ¬ēå·„å¤§å¦ | A three-way co-scanning optical coherence tomography handheld probe |
| EP3648703B1 (en) | 2017-07-04 | 2023-04-26 | Dentlytec G.P.L. Ltd. | Dental scanner with ultrasonic sensor component for augmentation of optical data |
| EP3658069B1 (en) | 2017-07-26 | 2024-06-26 | Dentlytec G.P.L. Ltd. | Intraoral scanner |
| JP7170340B2 (en) * | 2017-08-04 | 2022-11-14 | ć¦ććć¼ć·ćć£ć»ć«ć¬ććøć»ć³ć¼ćÆć¼ćć·ć§ćć«ć»ć¦ććć¼ć·ćć£ć»ćŖćć»ć¢ć¤ć«ć©ć³ćļ¼ć³ć¼ćÆ | Tissue penetrating surgical system and method |
| US10925525B2 (en) | 2017-08-18 | 2021-02-23 | Canon U.S.A., Inc. | Combined pulse oximetry and diffusing wave spectroscopy system and control method therefor |
| EP3741105A4 (en) * | 2018-02-16 | 2021-11-03 | Board of Supervisors of Louisiana State University And Agricultural and Mechanical College | DENTAL IMAGING WITHOUT IONIZING RADIATION THROUGH NEAR-INFRARED FLUORESCENCE AND RELATED SYSTEMS |
| EP3758587A4 (en) * | 2018-02-28 | 2022-02-09 | Live Vue Technologies Inc. | Apparatus and method for in vivo imaging of soft and hard tissue interfaces |
| WO2020144692A2 (en) | 2019-01-09 | 2020-07-16 | Dentlytec G.P.L. Ltd | Dental device with probe and methods associated therewith |
| CN110613440A (en) * | 2019-09-18 | 2019-12-27 | éå²åøåøē«å»é¢ | Coronary artery flow detection device and measurement method |
| WO2024076360A1 (en) * | 2022-10-04 | 2024-04-11 | Waypoint Orthopedics, Inc. | Orthopedic bone awl with optoelectronic feedback |
Family Cites Families (132)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4887606A (en) | 1986-09-18 | 1989-12-19 | Yock Paul G | Apparatus for use in cannulation of blood vessels |
| EP0273180B1 (en) | 1986-12-05 | 1991-06-12 | Siemens Aktiengesellschaft | Intracavitary ultrasonic scanning apparatus |
| US5006984A (en) | 1987-03-10 | 1991-04-09 | Stanford University | Bone/tissue analyzer and method |
| FI80204C (en) | 1987-10-14 | 1990-05-10 | Parma Oy | MAETFOERFARANDE OCH -ANORDNING BASERADE PAO ULTRALJUD FOER UNDERSOEKNING AV HAORDVAEVNADER. |
| DE3909140A1 (en) | 1989-03-21 | 1990-09-27 | Sauerwein Isotopen Tech | SYRINGE FOR DOPPLERSONOGRAPHICALLY ASSISTED POINTING |
| US5078147A (en) | 1990-01-25 | 1992-01-07 | Vivo Corporation | Method of noninvasive ultrasonic detection of nerve root inflammation |
| US5131395A (en) | 1990-03-28 | 1992-07-21 | Gehlbach Steve M | Ultrasonic apparatus for guiding needles into surface vessels |
| JPH0432708U (en) | 1990-07-13 | 1992-03-17 | ||
| US6485413B1 (en) | 1991-04-29 | 2002-11-26 | The General Hospital Corporation | Methods and apparatus for forward-directed optical scanning instruments |
| US6134003A (en) | 1991-04-29 | 2000-10-17 | Massachusetts Institute Of Technology | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
| US6564087B1 (en) | 1991-04-29 | 2003-05-13 | Massachusetts Institute Of Technology | Fiber optic needle probes for optical coherence tomography imaging |
| US5200604A (en) | 1991-08-07 | 1993-04-06 | Laser Engineering, Inc. | Handpiece optical proximity detector for disabling surgical laser beam |
| US5352974A (en) | 1992-08-14 | 1994-10-04 | Zircon Corporation | Stud sensor with digital averager and dual sensitivity |
| US5320529A (en) | 1992-09-09 | 1994-06-14 | Howard C. Weitzman | Method and apparatus for locating an ideal site for a dental implant and for the precise surgical placement of that implant |
| US5423321A (en) | 1993-02-11 | 1995-06-13 | Fontenot; Mark G. | Detection of anatomic passages using infrared emitting catheter |
| US5402781A (en) | 1993-03-03 | 1995-04-04 | Washington University | Method and apparatus for determining bone density and diagnosing osteoporosis |
| FR2704655B1 (en) | 1993-04-28 | 1995-07-21 | Sodern | Mini-camera for close detection of nuclear radiation emitted by a radioisotope and application to surgical assistance. |
| US5309915A (en) | 1993-06-07 | 1994-05-10 | Mte, Inc. | Apparatus for locating veins and arteries |
| IT1268599B1 (en) | 1994-01-14 | 1997-03-06 | Igea Srl | ULTRASONIC MEASURING SYSTEM FOR DETECTION OF DENSITY AND BONE STRUCTURE. |
| GB9408176D0 (en) | 1994-04-25 | 1994-06-15 | Interface Devices Distribution | Fluid level detectors |
| US5518008A (en) | 1994-08-25 | 1996-05-21 | Spectral Sciences Research Corporation | Structural analyzer, in particular for medical implants |
| US5543799A (en) | 1994-09-02 | 1996-08-06 | Zircon Corporation | Swept range gate radar system for detection of nearby objects |
| US6597941B2 (en) | 1994-09-15 | 2003-07-22 | Stryker Corporation | Transillumination of body members for protection during body invasive procedures |
| US5842149A (en) | 1996-10-22 | 1998-11-24 | Baker Hughes Incorporated | Closed loop drilling system |
| US6517487B1 (en) | 1995-03-01 | 2003-02-11 | Lunar Corporation | Ultrasonic densitometer with opposed single transducer and transducer array |
| US5772594A (en) | 1995-10-17 | 1998-06-30 | Barrick; Earl F. | Fluoroscopic image guided orthopaedic surgery system with intraoperative registration |
| US5688118A (en) | 1995-12-27 | 1997-11-18 | Denx Ltd. | Image sound and feeling simulation system for dentistry |
| US5651363A (en) | 1996-02-16 | 1997-07-29 | Orthologic Corporation | Ultrasonic bone assessment method and apparatus |
| US5678555A (en) | 1996-04-08 | 1997-10-21 | O'connell; Peter | Method of locating and marking veins |
| US6675033B1 (en) | 1999-04-15 | 2004-01-06 | Johns Hopkins University School Of Medicine | Magnetic resonance imaging guidewire probe |
| US5795295A (en) | 1996-06-25 | 1998-08-18 | Carl Zeiss, Inc. | OCT-assisted surgical microscope with multi-coordinate manipulator |
| US5917314A (en) | 1996-08-08 | 1999-06-29 | Zircon Corporation | Electronic wall-stud sensor with three capacitive elements |
| IL131080A0 (en) | 1997-01-28 | 2001-01-28 | William R Krause | Targeting device for relative positioning of a plurality of devices |
| AU6262698A (en) | 1997-02-04 | 1998-08-25 | National Aeronautics And Space Administration - Nasa | Multimodality instrument for tissue characterization |
| US5850184A (en) | 1997-06-25 | 1998-12-15 | Cobra Machine Tool Co., Inc. | Ultrasonic tool confirmation sensor |
| US6503249B1 (en) | 1998-01-27 | 2003-01-07 | William R. Krause | Targeting device for an implant |
| US6030221A (en) | 1998-02-11 | 2000-02-29 | Cavitat, Inc. | Ultrasonic apparatus and for precisely locating cavitations within jawbones and the like |
| AU6417599A (en) | 1998-10-08 | 2000-04-26 | University Of Kentucky Research Foundation, The | Methods and apparatus for (in vivo) identification and characterization of vulnerable atherosclerotic plaques |
| ATE306213T1 (en) | 1998-12-23 | 2005-10-15 | Nuvasive Inc | DEVICES FOR CANNULATION AND NERVE MONITORING |
| IL130618A (en) | 1999-06-23 | 2004-01-04 | Samer M Srouji | Ultrasound system for use in drilling implant cavities |
| US6471655B1 (en) | 1999-06-29 | 2002-10-29 | Vitalwave Corporation | Method and apparatus for the noninvasive determination of arterial blood pressure |
| KR100338975B1 (en) | 1999-09-14 | 2002-05-31 | ģµģė°±, ģ“찬경 | Method for detecting alveolar nerve within mandible |
| US7510536B2 (en) | 1999-09-17 | 2009-03-31 | University Of Washington | Ultrasound guided high intensity focused ultrasound treatment of nerves |
| US8239001B2 (en) | 2003-10-17 | 2012-08-07 | Medtronic Navigation, Inc. | Method and apparatus for surgical navigation |
| US6466817B1 (en) | 1999-11-24 | 2002-10-15 | Nuvasive, Inc. | Nerve proximity and status detection system and method |
| KR20020077346A (en) | 1999-11-24 | 2002-10-11 | ėė°ģėø ģøģ½ķ¼ė ģ“ķ°ė | Electromyography system |
| US7239909B2 (en) | 2000-01-19 | 2007-07-03 | Luminetx Technologies Corp. | Imaging system using diffuse infrared light |
| GB2361537A (en) | 2000-04-19 | 2001-10-24 | Robert Skidmore | Sensing apparatus and methods |
| AU2001259435A1 (en) * | 2000-05-03 | 2001-11-12 | Stephen T Flock | Optical imaging of subsurface anatomical structures and biomolecules |
| WO2001095790A1 (en) | 2000-06-16 | 2001-12-20 | The University Of British Columbia | Analysis of optic nerve head shape |
| US6491522B1 (en) | 2000-08-09 | 2002-12-10 | Charles D. Jensen | Dental diagnostic system and method |
| US6904123B2 (en) | 2000-08-29 | 2005-06-07 | Imaging Therapeutics, Inc. | Methods and devices for quantitative analysis of x-ray images |
| US6451009B1 (en) | 2000-09-12 | 2002-09-17 | The Regents Of The University Of California | OCDR guided laser ablation device |
| US6419484B1 (en) * | 2000-09-12 | 2002-07-16 | The Regents Of The University Of California | Optical coherence tomography guided dental drill |
| US7231243B2 (en) | 2000-10-30 | 2007-06-12 | The General Hospital Corporation | Optical methods for tissue analysis |
| JP4562106B2 (en) | 2000-11-27 | 2010-10-13 | ć»ć¤ć³ć¼ć¤ć³ć¹ćć«ę Ŗå¼ä¼ē¤¾ | Ultrasonic diagnostic equipment |
| DE60207982T2 (en) | 2001-01-24 | 2006-06-14 | Geolink Uk Ltd | Bohrsignalgebungssystem |
| WO2002096261A2 (en) | 2001-05-31 | 2002-12-05 | Denx America, Inc. | Image guided implantology methods |
| CA2449567A1 (en) | 2001-06-13 | 2002-12-19 | Ckm Diagnostics, Inc. | Non-invasive method and apparatus for tissue detection |
| US6620101B2 (en) | 2001-07-26 | 2003-09-16 | Dentosonic Ltd. | Bone measurement device |
| JP2005503857A (en) | 2001-09-25 | 2005-02-10 | ććć·ćļ¼ ć¤ć³ć³ć¼ćć¬ć¤ććć | Systems and methods for performing surgical procedures and surgical diagnosis |
| US6939310B2 (en) * | 2001-10-10 | 2005-09-06 | Lifescan, Inc. | Devices for physiological fluid sampling and methods of using the same |
| US6980299B1 (en) | 2001-10-16 | 2005-12-27 | General Hospital Corporation | Systems and methods for imaging a sample |
| JP2005506867A (en) | 2001-10-24 | 2005-03-10 | ć«ććć£ć³ć° ćØććø ćµć¼ćøć«ć«ļ¼ ć¤ć³ć³ć¼ćć¬ć¤ććć | Intraosseous ultrasound during surgical implantation |
| US7664544B2 (en) | 2002-10-30 | 2010-02-16 | Nuvasive, Inc. | System and methods for performing percutaneous pedicle integrity assessments |
| US6990222B2 (en) | 2001-11-21 | 2006-01-24 | Arnold Ben A | Calibration of tissue densities in computerized tomography |
| US7310150B2 (en) | 2002-01-11 | 2007-12-18 | The General Hospital Corporation | Apparatus and method for low coherence ranging |
| DE10202515B4 (en) | 2002-01-23 | 2004-08-12 | Holberg, Christof, Dr. | Method, device and computer program product for creating an individual model of a jawbone |
| US7355716B2 (en) | 2002-01-24 | 2008-04-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
| US6726325B2 (en) | 2002-02-26 | 2004-04-27 | Carl Zeiss Meditec, Inc. | Tracking assisted optical coherence tomography |
| AU2003231354A1 (en) | 2002-06-05 | 2003-12-22 | Nervetrack Ltd. | Method and apparatus for measuring nerve signals in nerve fibers |
| US7582058B1 (en) | 2002-06-26 | 2009-09-01 | Nuvasive, Inc. | Surgical access system and related methods |
| US7758342B2 (en) | 2002-07-26 | 2010-07-20 | Aseptico, Inc. | Detecting and indicating a proximity of a dental instrument to a tooth apical foramen |
| US6665948B1 (en) | 2002-09-05 | 2003-12-23 | Scott Hal Kozin | Drill bit penetration measurement system and method |
| US7271706B2 (en) | 2002-10-09 | 2007-09-18 | The University Of Mississippi | Termite acoustic detection |
| US7074187B2 (en) | 2002-12-13 | 2006-07-11 | Selzer Robert H | System and method for improving ultrasound image acquisition and replication for repeatable measurements of vascular structures |
| WO2004054447A1 (en) | 2002-12-18 | 2004-07-01 | Koninklijke Philips Electronics N.V. | Ultrasonic apparatus for estimating artery parameters |
| JP3964795B2 (en) | 2003-01-07 | 2007-08-22 | ē¬ē«č”ęæę³äŗŗē§å¦ęč”ęÆčę©ę§ | Osteoporosis diagnosis support device using panoramic X-ray image |
| US7691057B2 (en) | 2003-01-16 | 2010-04-06 | Nuvasive, Inc. | Surgical access system and related methods |
| AU2004206998B2 (en) | 2003-01-24 | 2009-12-17 | The General Hospital Corporation | System and method for identifying tissue using low-coherence interferometry |
| US8054468B2 (en) | 2003-01-24 | 2011-11-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
| US6851487B1 (en) | 2003-04-04 | 2005-02-08 | Marcus J. Shotey | Power tool and beam location device |
| US20050038343A1 (en) | 2003-07-10 | 2005-02-17 | Alfred E. Mann Institute For Biomedical Research At The University Of Southern California | Apparatus and method for locating a bifurcation in an artery |
| US7081110B2 (en) | 2003-07-17 | 2006-07-25 | The Procter & Gamble Company | Applicator having an indented fingergrip with raised portions |
| JP4077430B2 (en) | 2003-07-31 | 2008-04-16 | ä½³ē„ é«ē³ | Bone density evaluation apparatus and bone density evaluation method |
| GB2404738B (en) | 2003-08-04 | 2005-09-28 | Schlumberger Holdings | System and method for sensing using diamond based microelectrodes |
| WO2005013805A2 (en) | 2003-08-05 | 2005-02-17 | Nuvasive, Inc. | Systemand methods for performing dynamic pedicle integrity assessments |
| US7307734B2 (en) * | 2003-08-14 | 2007-12-11 | University Of Central Florida | Interferometric sensor for characterizing materials |
| US7285093B2 (en) | 2003-10-10 | 2007-10-23 | Imadent Ltd. | systems for ultrasonic imaging of a jaw, methods of use thereof and coupling cushions suited for use in the mouth |
| EP3009815B1 (en) | 2003-10-27 | 2022-09-07 | The General Hospital Corporation | Method and apparatus for performing optical imaging using frequency-domain interferometry |
| US7244234B2 (en) | 2003-11-11 | 2007-07-17 | Soma Development Llc | Ultrasound guided probe device and method of using same |
| WO2005058154A1 (en) * | 2003-12-16 | 2005-06-30 | Medeikon Corporation | Method for monitoring of analytes in biological samples using low coherence interferometry |
| US20050142517A1 (en) * | 2003-12-30 | 2005-06-30 | Howard Frysh | System for producing a dental implant and method |
| IL160216A0 (en) | 2004-02-04 | 2004-07-25 | Yosef Gross | Dental assembly |
| US9801527B2 (en) | 2004-04-19 | 2017-10-31 | Gearbox, Llc | Lumen-traveling biological interface device |
| JP4995720B2 (en) * | 2004-07-02 | 2012-08-08 | ć¶ ćøć§ćć©ć« ćć¹ććæć« ć³ć¼ćć¬ć¤ć·ć§ć³ | Endoscopic imaging probe with double clad fiber |
| US20060015041A1 (en) | 2004-07-13 | 2006-01-19 | Brian Neal | Periodontal pocket depth recorder |
| US7267546B2 (en) | 2004-08-09 | 2007-09-11 | Ultradent Products, Inc. | Light meter for detecting and measuring intensity of two or more wavelengths of light |
| US7824348B2 (en) | 2004-09-16 | 2010-11-02 | Guided Therapy Systems, L.L.C. | System and method for variable depth ultrasound treatment |
| EP2329759B1 (en) | 2004-09-29 | 2014-03-12 | The General Hospital Corporation | System and method for optical coherence imaging |
| WO2006042241A2 (en) | 2004-10-08 | 2006-04-20 | Nuvasive, Inc. | Surgical access system and related methods |
| US7916921B2 (en) | 2004-10-19 | 2011-03-29 | Hiroshima University Independent Administrative Agency | Osteoporosis diagnosis support device |
| US7319639B2 (en) | 2004-12-20 | 2008-01-15 | Luna Innovations Incorporated | Acoustic concealed item detector |
| WO2006072050A2 (en) | 2004-12-30 | 2006-07-06 | Nuvasive, Inc. | System and methods for monitoring during anterior surgery |
| US7725169B2 (en) * | 2005-04-15 | 2010-05-25 | The Board Of Trustees Of The University Of Illinois | Contrast enhanced spectroscopic optical coherence tomography |
| JP2008538612A (en) | 2005-04-22 | 2008-10-30 | ć¶ ćøć§ćć©ć« ćć¹ććæć« ć³ć¼ćć¬ć¤ć·ć§ć³ | Configuration, system, and method capable of providing spectral domain polarization sensitive optical coherence tomography |
| US7411517B2 (en) | 2005-06-23 | 2008-08-12 | Ultima Labs, Inc. | Apparatus and method for providing communication between a probe and a sensor |
| EP1741394A1 (en) * | 2005-07-08 | 2007-01-10 | Technische Universiteit Delft | Surgical drill system and surgical drill bit to be used therein |
| US20070122344A1 (en) | 2005-09-02 | 2007-05-31 | University Of Rochester Medical Center Office Of Technology Transfer | Intraoperative determination of nerve location |
| BRPI0504065A (en) | 2005-09-06 | 2007-05-22 | Ronaldo Piazzalunga | root spectral attenuation coefficient for use in endodontic foraminal locator |
| KR101297143B1 (en) | 2005-11-27 | 2013-08-21 | ģģæ ģ“ķģ¤ ė©ė컬 리미ķ°ė | Assessment of structures such as bone using spatial-frequency analysis |
| US7801343B2 (en) | 2005-11-29 | 2010-09-21 | Siemens Medical Solutions Usa, Inc. | Method and apparatus for inner wall extraction and stent strut detection using intravascular optical coherence tomography imaging |
| CN101351157A (en) | 2006-01-03 | 2009-01-21 | ēå®¶é£å©ęµ¦ēµåč”份ęéå ¬åø | Methods and systems for locating blood vessels |
| GB0607270D0 (en) * | 2006-04-11 | 2006-05-17 | Univ Nottingham | The pulsing blood supply |
| WO2010058398A2 (en) * | 2007-03-08 | 2010-05-27 | Sync-Rx, Ltd. | Image processing and tool actuation for medical procedures |
| JP4918383B2 (en) | 2007-03-16 | 2012-04-18 | ćŖćŖć³ćć¹ę Ŗå¼ä¼ē¤¾ | Outline detecting apparatus, outline detecting method and program thereof |
| US20080253627A1 (en) | 2007-04-11 | 2008-10-16 | Searete LLC, a limited liability corporation of | Compton scattered X-ray visualization, imaging, or information provider using image combining |
| US8041006B2 (en) | 2007-04-11 | 2011-10-18 | The Invention Science Fund I Llc | Aspects of compton scattered X-ray visualization, imaging, or information providing |
| US7602184B2 (en) | 2007-04-30 | 2009-10-13 | The Regents Of The University Of California | Magnetic resonance spectroscopic imaging with short echo times |
| RU2370225C2 (en) | 2007-05-21 | 2009-10-20 | ŠŠ¾ŃŃŠ“аŃŃŃŠ²ŠµŠ½Š½Š¾Šµ Š¾Š±ŃŠ°Š·Š¾Š²Š°ŃŠµŠ»ŃŠ½Š¾Šµ ŃŃŃŠµŠ¶Š“ение вŃŃŃŠµŠ³Š¾ ŠæŃŠ¾ŃеŃŃŠøŠ¾Š½Š°Š»Ńного Š¾Š±ŃŠ°Š·Š¾Š²Š°Š½ŠøŃ "ТвеŃŃŠŗŠ°Ń гоŃŃŠ“аŃŃŃŠ²ŠµŠ½Š½Š°Ń Š¼ŠµŠ“ŠøŃŠøŠ½ŃŠŗŠ°Ń Š°ŠŗŠ°Š“ŠµŠ¼ŠøŃ Š¤ŠµŠ“ŠµŃŠ°Š»Ńного агенŃŃŃŠ²Š° по Š·Š“ŃŠ°Š²Š¾Š¾Ń ŃŠ°Š½ŠµŠ½ŠøŃ Šø ŃŠ¾ŃŠøŠ°Š»ŃŠ½Š¾Š¼Ń ŃŠ°Š·Š²ŠøŃŠøŃ" | Method of providing safe operative access to temporomandibular joint and condylar process of mandible |
| US7993138B2 (en) | 2007-08-21 | 2011-08-09 | Buchanan L Stephen | Apex locator for endodontic procedures |
| US8738116B2 (en) * | 2007-09-21 | 2014-05-27 | National Research Council Of Canada | Method and apparatus for periodontal diagnosis |
| US20090108205A1 (en) | 2007-10-10 | 2009-04-30 | Cas Medical Systems, Inc. | Nirs sensor mounting apparatus |
| US9672471B2 (en) | 2007-12-18 | 2017-06-06 | Gearbox Llc | Systems, devices, and methods for detecting occlusions in a biological subject including spectral learning |
| US20090281412A1 (en) | 2007-12-18 | 2009-11-12 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System, devices, and methods for detecting occlusions in a biological subject |
| US20090281413A1 (en) | 2007-12-18 | 2009-11-12 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems, devices, and methods for detecting occlusions in a biological subject |
| US20090287076A1 (en) | 2007-12-18 | 2009-11-19 | Boyden Edward S | System, devices, and methods for detecting occlusions in a biological subject |
| WO2009153719A1 (en) * | 2008-06-17 | 2009-12-23 | Koninklijke Philips Electronics N.V. | Method and device for optically examining the interior of turbid media |
| US20100056922A1 (en) | 2008-09-02 | 2010-03-04 | Thierry Florent | Method and diagnostic ultrasound apparatus for determining the condition of a person's artery or arteries |
| US8266718B2 (en) * | 2009-02-20 | 2012-09-11 | The Board Of Trustees Of Leland Stanford Junior University | Modulated microwave microscopy and probes used therewith |
| JP2011177009A (en) | 2010-01-26 | 2011-09-08 | Equos Research Co Ltd | Contactless power transmission system |
| US20140058226A1 (en) * | 2010-12-22 | 2014-02-27 | Boris M. Chernobrod | Method and Apparatus for In Vivo Optical Measurement of Blood Glucose Concentration |
-
2011
- 2011-12-19 US US13/329,557 patent/US9179843B2/en active Active
-
2012
- 2012-01-04 ES ES12774529.7T patent/ES2635539T3/en active Active
- 2012-01-04 WO PCT/IB2012/050045 patent/WO2012143798A1/en not_active Ceased
- 2012-01-04 DK DK12774529.7T patent/DK2699165T3/en active
- 2012-01-04 EP EP12774529.7A patent/EP2699165B1/en active Active
- 2012-01-04 CA CA2833432A patent/CA2833432C/en active Active
-
2015
- 2015-11-06 US US14/934,603 patent/US10258350B2/en active Active
-
2019
- 2019-03-04 US US16/291,391 patent/US20190192173A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240173039A1 (en) * | 2022-11-29 | 2024-05-30 | Metal Industries Research & Development Centre | Detection method for surgical drilling and end effector used therein |
Also Published As
| Publication number | Publication date |
|---|---|
| US10258350B2 (en) | 2019-04-16 |
| CA2833432A1 (en) | 2012-10-26 |
| CA2833432C (en) | 2014-07-22 |
| US20190192173A1 (en) | 2019-06-27 |
| US20160058455A1 (en) | 2016-03-03 |
| US20120271176A1 (en) | 2012-10-25 |
| WO2012143798A1 (en) | 2012-10-26 |
| ES2635539T3 (en) | 2017-10-04 |
| DK2699165T3 (en) | 2017-09-25 |
| EP2699165A1 (en) | 2014-02-26 |
| US9179843B2 (en) | 2015-11-10 |
| EP2699165A4 (en) | 2014-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2699165B1 (en) | System for optically evaluating proximity to the inferior alveolar nerve in situ | |
| US7796243B2 (en) | Detection and monitoring of changes in mineralized tissues or calcified deposits by optical coherence tomography and Raman spectroscopy | |
| JP5739471B2 (en) | Apparatus for diagnosing dental defects using infrared photothermal radiometry (PTR) and modulated laser luminescence (LUM) | |
| Feldchtein et al. | In vivo OCT imaging of hard and soft tissue of the oral cavity | |
| Shemesh et al. | The ability of optical coherence tomography to characterize the root canal walls | |
| WO2010104198A1 (en) | Dental cutter | |
| Mohamad Saberi et al. | Assessment of demineralized tooth lesions using optical coherence tomography and other state-of-the-art technologies: a review | |
| JP4338142B2 (en) | Dental optical tomographic image display system | |
| Alifkalaila et al. | Photoacoustic imaging system based on diode laser and condenser microphone for characterization of dental anatomy | |
| JP2006191937A (en) | Variable wavelength light generator for optical interference tomography of teeth and optical interference tomography device of teeth | |
| Fried | Optical methods for monitoring demineralization and caries | |
| HK1195467A (en) | System for optically evaluating proximity to the inferior alveolar nerve in situ | |
| HK1195467B (en) | System for optically evaluating proximity to the inferior alveolar nerve in situ | |
| US12082908B2 (en) | Devices and methods for the intra-operative verification of oral health procedures | |
| Canjau et al. | Minimally-invasive diagnostic approaches in periodontics: laser Doppler imaging and optical coherence tomography | |
| Moore et al. | Photoacoustic Ultrasound for Enhanced Contrast in Dental and Periodontal Imaging | |
| Colston Jr et al. | OCT for diagnosis of periodontal disease | |
| Yu | Dental pulp location and dentin thickness assessment in situ with diffuse reflectance spectroscopy | |
| van Soest et al. | Optical coherence tomography for endodontic imaging | |
| Ourutina et al. | In-vivo optical coherent tomography of teeth and oral mucosa | |
| Abdul et al. | A Review on Optical Coherence Tomography (OCT) Technique in Dentistry Application: Limitations and Challenges | |
| JP2014054482A (en) | Imaging probe for oct apparatus | |
| Everett et al. | Fiber optic-based optical coherence tomography (OCT) for dental applications | |
| Kim et al. | Early detection of dental caries using photoacoustics | |
| Cubeddu et al. | Time-resolved optical mammograph for clinical studies beyond 900 nm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20131107 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20140605 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/00 20060101ALI20140530BHEP Ipc: A61B 5/1455 20060101ALI20140530BHEP Ipc: A61C 8/00 20060101ALI20140530BHEP Ipc: A61B 6/14 20060101AFI20140530BHEP Ipc: A61C 19/04 20060101ALI20140530BHEP |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20140829 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1195467 Country of ref document: HK |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20150701 |
|
| INTC | Intention to grant announced (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: LIVE VUE TECHNOLOGIES INC. |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602012033242 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61B0006140000 Ipc: A61B0005026000 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/1455 20060101ALI20161118BHEP Ipc: A61C 1/08 20060101ALI20161118BHEP Ipc: A61B 17/16 20060101ALI20161118BHEP Ipc: A61B 17/17 20060101ALI20161118BHEP Ipc: A61C 19/04 20060101ALI20161118BHEP Ipc: A61B 5/026 20060101AFI20161118BHEP Ipc: A61B 5/00 20060101ALI20161118BHEP Ipc: A61C 8/00 20060101ALI20161118BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20161221 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 898593 Country of ref document: AT Kind code of ref document: T Effective date: 20170615 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602012033242 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20170919 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2635539 Country of ref document: ES Kind code of ref document: T3 Effective date: 20171004 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170607 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170907 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170908 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170907 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171007 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602012033242 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20180308 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1195467 Country of ref document: HK |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180104 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20180131 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180131 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180104 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20120104 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170607 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: UEP Ref document number: 898593 Country of ref document: AT Kind code of ref document: T Effective date: 20170607 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230505 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20241218 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20241218 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20241219 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20241219 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20241220 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20241219 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20241218 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20250203 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20250201 Year of fee payment: 14 Ref country code: AT Payment date: 20241220 Year of fee payment: 14 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20250107 Year of fee payment: 14 |